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“The noblest pleasure is the joy of understanding” Leonardo da Vinci 1452-1519  
An insufficient vascularization of the wound site is often the cause of failure in tissue 
regeneration. Although the use of cell therapy or growth factors has introduced promising 
results, they are risky, expensive and difficult to store. Synthetic biomaterials offer an 
alternative, reducing these limitations but at the same time decreasing also the positive 
effects. Among synthetic materials, degradable calcium phosphates have demonstrated 
an efficient bioactivity. Their partial dissolution towards the surrounding tissue induces 
several positive responses including cell migration, proliferation and even osteogenic 
differentiation. What is not so well understood is their angiogenic (formation of blood 
vessels from pre-existing ones) potential. Recent findings in our group indicates that their 
Ca2+ release is involved in the cell synthesis of angiogenic factors such as the VEGF. 
Based on this finding, in this thesis, we synthesized binary (P2O5-CaO) calcium 
phosphate glass (CPg) degradable nanoparticles by the sol-gel method and tested and 
validated their angiogenic potential in vitro and in vivo. Interestingly, this is the first time 
that binary (P2O5-CaO) CPg nanoparticles have been synthesized by the sol-gel method. 
We used ethylphosphate and calcium 2-methoxyethoxide as sol-gel precursors, and we 
catalyzed the precipitation of the particles using NH3(aq) in an ethanolic medium. Nuclear 
magnetic resonance supplemented with other characterization techniques, showed that 
the particles were a mixture of highly soluble amorphous calcium monoethylphosphate 
with the formation of portlandite or NH4H2PO4 for an excess or the absence of Ca 
respectively. After a thermal treatment at 200 or 350 ºC, the highly soluble organic 
particles were converted into more stable (but still degradable) inorganic amorphous 
calcium trimetaphosphate (ACTMP), pyrophosphate (ACPP), orthophosphate (ACP) and 
calcite, as the Ca content of the particles increased respectively. We controlled the ion 
release of the particles under physiological conditions by modifying their Ca/P ratio and 
applying this moderately low thermal treatment. The CPg nanoparticles were combined 
with electrospun polylactic acid nanofibers in order to develop implantable scaffolds. The 
Ca2+ releasing scaffolds showed promising results in angiogenesis, including a similar 
blood vessel formation than significant VEGF doses in the chick chorioallantioc 
membrane model. The scaffolds also induced a stronger osteogenic differentiation, and 
a significant skin ulcer reduction in diabetic and obese mice, that validates their use not 
only for bone but also for the healing of highly vascularized softer tissues such as skin. 
Concluding, we demonstrated that the use of synthetic Ca2+ releasing scaffolds free from 
biological molecules or drugs, offers a cost-effective alternative for the regeneration of 
highly vascularized tissues.  
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Glossary 
A 
ACP: Amorphous calcium orthophosphate 
ACPP: Amorphous calcium pyrophosphate 
ACTM: Amorphous calcium trimetaphosphate 
ATR-FTIR: Attenuated total reflectance infrared spectroscopy 
C 
C: Carbon 
CAM: Chick chorioallantoic membrane 
CD31: Cluster of differentiation 31 
CMEO: Calcium 2-methoxyethoxide 
CMEP: Calcium monoethylphosphate 
CP: Calcium phosphates 
CPc: Calcium phosphate ceramics 
CPg: Calcium phosphate glasses 
CaSR: Calcium-sensing receptor 
D 
D2O: Deuterium oxide (heavy water) 
DEP: Diethylphosphate 
DLS: Dynamic Light Scattering 
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DMEM: Dulbecco’s modified essential medium 
DSC: Differential scanning calorimetry 
E 
EA: Elemental analysis 
ECM: Extracellular matrix/Extracted culture medium 
EDS: Energy dispersive X-ray spectroscopy 
EPCs: Endothelial progenitor cells 
ERM: Extracted regular medium 
ESI-MS: Electrospray ionization mass spectrometry 
F 
FBS: Fetal bovine serum 
FE-SEM: Field emission scanning electron microscopy  
H 
HA: Hydroxyapatite 
hDFs: Human dermal fibroblasts 
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
hMSCs: Human mesenchymal stem cells 
1H NMR: Proton nuclear magnetic resonance 
HUVECs: Human umbilical vein endothelial cells 
M  
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MEOH: 2-methoxyethanol 
MEM: Minimum essential medium 
MEP: Monoethylphosphate 
MSCs: Mesenchymal stem cells 
N 
NC: Negative control 
O 
OM: Osteogenic medium 
P 
PBS: Phosphate buffered saline solution 
Pi: Inorganic phosphate 
PLA: Polylactic acid 
31P MAS NMR: Phosphorus magnetic angle spinning nuclear magnetic resonance  
31P NMR: Phosphorus nuclear magnetic resonance 
Q 
Qn: Condensed phosphate units 
R 
RM: Regular medium 
RT: Room temperature 
S 
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SEM: Standard error of the mean 
T 
TCC: Total carbon content 
TCP: Tissue culture plate 
TEP: Triethylphosphate 
Tg: Glass transition temperature 
TOC: Total organic carbon 
V  
VEGF: Vascular endothelial growth factor 
X 
XRD: X-ray diffraction 
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Objectives 
The aim of this thesis was to develop, characterize and study biodegradable and 
biocompatible synthetic scaffolds with controllable Ca2+ release to stimulate the 
vascularization and the healing of hard-to-heal wounds. This objective has been based 
on previous studies performed by a former PhD student of the group (Dr. Aitor Aguirre) 
that demonstrated that specific physiological Ca2+ concentrations played a crucial role in 
angiogenesis (i.e. formation of blood vessels from pre-existing ones) [1]. Since a poor 
vascularization is often the main drawback in the regeneration of chronic and hard-to-
heal wounds, a Ca2+-releasing strategy has been adopted to develop synthetic scaffolds 
to overcome this problem. The trend was to avoid biological components (e.g. growth 
factors, active proteins, drugs) that hinder their translation to the market due to money-
cost, unpredictable responses and difficult storage. The development of the scaffolds 
was based on previous studies performed by another former PhD student (Dr. Nadège 
Sachot), who worked in the development of composite materials for the healing of critical 
bone fractures and angiogenesis [2,3]. Since I did not develop some of the scaffold 
manufacturing protocols (e.g. electrospinning), their parameters are not widely 
discussed in the materials and methods sections.  
Following, I will describe in more detail the specific objectives of this thesis; 
- Develop and characterize by the sol-gel method Ca2+ releasing nanoparticles with 
controlled degradability, containing only known metabolizable components, and 
susceptible to be embedded into polymeric nanofibrous scaffolds. 
- Study by nuclear magnetic resonance spectroscopy and other complementary 
techniques the chemical structure of the sol-gel precursors, the sol-gel reaction and the 
synthesized nanoparticles. Correlate the chemical structure of the particles with their 
composition and degradability. 
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- Developed and characterize implantable scaffolds by the electrospinning technique, 
using polylactic acid and containing different amounts of the synthesized nanoparticles 
to release different Ca2+ concentrations in physiological conditions. 
- Evaluate the in vitro angiogenic potential of the developed scaffolds and their potential 
application in bone regeneration. Correlate the Ca2+ released with the induced 
angiogenesis. 
- Evaluate the in vitro and in vivo applicability of the developed scaffolds for the treatment 
of chronic skin wounds and correlate the results with current clinic treatments.  
 
 
[1] A. Aguirre, A. González, M. Navarro, Ó. Castaño, J.A. Planell, E. Engel, Control 
of microenvironmental cues with a smart biomaterial composite promotes 
endothelial progenitor cell angiogenesis, Eur. Cells Mater. 24 (2012) 90–106. 
doi:10.22203/eCM.v024a07. 
[2] N. Sachot, O. Castaño, H. Oliveira, J. Martí-Muñoz, A. Roguska, J. Amedee, M. 
Lewandowska, J.A. Planell, E. Engel, A novel hybrid nanofibrous strategy to 
target progenitor cells for cost-effective in situ angiogenesis, J. Mater. Chem. B. 
4 (2016) 6967–6978. doi:10.1039/C6TB02162J. 
[3] O. Castaño, N. Sachot, E. Xuriguera, E. Engel, J.A. Planell, J.-H. Park, G.-Z. Jin, 
T.-H. Kim, J.-H. Kim, H.-W. Kim, Angiogenesis in Bone Regeneration : Tailored 
Calcium Release in Hybrid Fibrous Scaffolds, ACS Appl. Mater. Interfaces. 6 
(2014) 7512−7522. doi:10.1021/am500885v. 
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Chapter 1. Calcium phosphate 
glasses: An overview on their 
angiogenic potential and uses in 
bone and wound healing 
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1.1. Calcium phosphate glasses (CPg) 
 
Phosphate glasses have been avoided in many fields despite their unique properties 
(e.g. high thermal expansion, low melting temperatures, optical properties) due to their 
high solubility in aqueous media [1]. For this reason, the less unique but more stable 
silicate glasses have overcome their use in many applications [2]. This is the case of 
biomaterials, whose initial aim was to replace the body mechanics by being long-term 
substitutes [3]. However, when new 3rd generation of biomaterials started to seek to 
interact with the body and be totally replaced by its own tissue, soluble phosphate 
glasses started to gain importance [3]. One of the first studies using a pure phosphate 
glass system for tissue regeneration applications was published in 2000 [4,5]. Salih et 
al. [5] tested how the ions released by a soluble P2O5-CaO-Na2O glass system affected 
the in vitro behavior of osteoblasts. They demonstrated that by easy modification of the 
glass composition they could achieve different dissolution rates. The introduction of 
several ions within the P2O5 glass network has been used to create and disrupt different 
chemical bonds and modified the properties and stability of the bulk glass [2]. By far, the 
most used ion in phosphate glasses for biomedical applications has been Ca2+ due to 
their biocompatibility and good affinity with the glass P2O5 network [2,6]. The P2O5-CaO 
glass systems are known as calcium phosphate glasses (CPg). Their solubility  and 
similar composition to the biological hydroxyapatite (HA) give an alternative to the long 
being used crystalline CP ceramics (CPc) in bone regenerative applications [7]. Among 
different advantages of CPg regarding CPc and calcium phosphate glass-ceramics, we 
can highlight their non-stochiometric composition, which allows a wider range of possible 
combinations with different properties, a higher and more homogeneous degradability 
due to the absence of different crystalline phases with different solubility, and the 
possibility to easily incorporate extra ions (Cu2+, Co2+, Zn2+, Ag3+, Ti4+, etc.)  to achieve 
diverse properties and bioactive responses (e.g. angiogenesis, antimicrobial effects, 
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osteogenesis) [4,8–11]. Although, the composition of CPg is ideal for bone regenerative 
applications, the high control over their solubility, their nanoscalability and the release of 
specific ions to induce specific bioactivity, also suggest the use of CPg for other biological 
applications [12–14].  
  
 
1.2. Methods of synthesis 
 
The most common method to produce glasses has been by far the melt-quenching 
technique [3]. Melt-quenching consists of melting a mixture of metal oxides or salts above 
their melting point temperature and then quench it quickly below the crystallization 
temperature to avoid the formation of crystalline phases. This process allows the 
formation of a different variety of glasses (i.e. borate, silicate, phosphate, etc.) including 
CPg for biomedical applications [8,15]. As advantages, melt-quenching allows an easy 
modification of the CPg composition by changing the amount of the metal oxides or salts 
before melting. However, the high temperatures applied (>1200ºC), apart from being 
high energy consuming (which is translated in an elevated money cost), result in the 
production of dense bulk glasses very difficult to nanostructured [3,7,16]. This is a 
limitation since biomedical devices often need to be tuned in the micro/nanoscale to 
improve their biological functions [17]. It is for this reason that in the last couple of 
decades, a low temperature glass synthesis method has gained importance. This 
process is known as the sol-gel method and consists of synthesizing glass networks by 
condensing metal alkoxides and/or salts in solution at low temperatures (Figure 1) 
[16,18]. The use of different alkoxide ratios also allows a high control over the final glass 
composition while the low temperatures applied minimize atom diffusion and sintering, 
permitting a higher control over the micro/nanostructure (e.g. nanoporosity, 
nanoparticles, etc.). However, the yields are often lower than in the melt-quenching 
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technique, and the glasses, if not thermally treated, will contain the presence of organics, 
which can modify the glass properties and have possible cytotoxic effects [16,19]. The 
sol-gel method is being widely used in many studies to produce nanostructured CPg 
combined with biocompatible polymers to produce composites with improved properties 
[12,20,21], as we will discuss in section 1.8.. In this thesis, we used the sol-gel method 
to synthesize pure binary (P2O5:CaO) CPg nanoparticles without extra ions that can 
hinder the synthesis and biocompatibility of the glass. We modified the degradability of 
the glasses by changing their P/Ca ratio and applying moderately low thermal 
treatments. 
 
 
 
Figure 1. Sol-gel synthesis scheme of silicon glasses. Hydrolysis of the silicon alkoxide 
(1). Condensation of the hydrolyzed silicon alkoxides to form a silicate glass network 
(2). Image from [15] with permission. 
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1.3. Chemical structure and characterization 
 
A glass can be defined as an amorphous network of condensed oxides. Such network 
allows the incorporation of extra ions able to modify the glass properties through different 
chemical interactions. In the case of CPg, the glass network is composed by condensed 
phosphate tetrahedrons (Qn) and the extra incorporated ions are mainly Ca2+. Other ions 
such as Na+ or Ti4+ can be also incorporated in smaller proportions for a better 
adjustment of the glass solubility and/or introduce a specific bioactivity [2,8]. The stability 
of the glass will depend on the amount and type of interactions between the ions and the 
phosphate network. For instance, ions with high valence (e.g. Ca2+, Ti4+) will tend to 
increase the stability of the glass while monovalent ions (e.g. K+, Na+) can be used to 
increase its solubility as they will break the phosphate network not allowing connectivity 
with other fragments  [8,22,23]. On the other hand, an excessive amount of extra ions 
will disrupt the condensed network leading to the formation of amorphous calcium 
phosphate salts. In the case of CPg, there is not much information about the chemical 
structure when Ca2+>50% [2]. As we will see in Chapter 2, the phosphate network is 
disrupted into amorphous calcium trimetaphosphates (ACTMP), pyrophosphates 
(ACPP) and orthophosphates (ACP) as the Ca2+ content increases respectively 
[2,24,25]. The characterization of glasses is not trivial due to their amorphous nature. X-
ray diffraction, an efficient tool to characterize crystalline CPc, is fairly ineffective with 
glasses. It can be used to discard the presence of crystalline phases in a glass system 
and to confirm and quantify its amorphous structure (Figure 2), but it does not 
differentiate among different amorphous phases like CPg or ACP [26].  
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Figure 2 Typical X-ray diffraction spectrum of a CPg showing its amorphous structure. 
 
 
The maximum expression of a phosphate glass is P2O5, which is composed by 
phosphate units linked to three other phosphates (Q3) (Figure 3) [2]. The introduction of 
Ca2+ will disrupt the condensed phosphate interactions converting the P2O5 in cyclic (Q2) 
or open-chained (Q2 and Q1) metaphosphates [2]. A further increase of Ca2+ will shorten 
the length of the metaphosphates increasing the amount Q1 units (pyrophosphates) until 
their total isolation into orthophosphate units (Q0) [2,24,25]. 
 
 
Figure 3. The different Qn units of CPg. M+ refers to the addition of monovalent cations. 
Image adapted from [2] with permission. 
 
Phosphorus nuclear magnetic resonance (31P NMR) spectroscopy can detect the 
amount and type of these Qn units (Figure 4). It is very sensitive to changes in the 
covalent bonds surrounding the 31P nuclei, being very useful to characterize CPg [24].  
31P NMR can also show differences depending on the extra cations introduced (e.g. Ca2+, 
Na2+, Ti4+, etc.) [24]. However, the ionic nature of such bonds results in small peak shifts 
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very difficult to identify. The use of NMR for these other ions or even oxygen does not 
give much information since the low abundance of the isotopes (43Ca, 23Na, 17O, etc.) 
and their quadrupole moment result in long spectra acquisition times and broad signals 
difficult to interpret [27,28]. Nowadays, 31P NMR is the most accessible and efficient 
technique to characterize CPg and can be combined with X-ray diffraction or infrared 
spectroscopy (FTIR) to extend or support the given information [18,29]. In this thesis, we 
mostly relied on 31P NMR spectroscopy combined with X-ray diffraction, FTIR 
spectroscopy and other complementary techniques, to characterize the synthesized CPg 
nanoparticles. 
 
Figure 4. 31P MAS NMR spectrum of a CPg showing its different Qn units. 
 
 
 
1.4. Bone regenerative applications 
 
The similar composition to bone hydroxyapatite (HA) and the solubility of CPg make their 
use ideal for bone regenerative applications [5]. Hench et al. developed in the late 60s 
the first synthetic material that chemically bind to bone. This material was a 45SiO2-
24.5CaO-24.5Na2O-6P2O5 glass system (Bioglass®) and it was a revolution since at that 
time there were many rejections of implanted metal alloys [16,30]. Moreover, the 
discovery of a synthetic material with such properties offered an alternative to the 
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expensive and risky use of growth factors such as bone morphogenetic proteins (BMPs) 
[31–33].  There are two described mechanisms that attempt to explain the good 
integration of Bioglass® with bone. The first and more accepted mechanism 
hypothesizes that the precipitation of HA due to the partial dissolution of the glass is the 
responsible of the good integration with bone [16]. The second mechanism proposes 
that the ions released by the glass directly stimulate bone progenitor cells to be 
differentiated and produce bone [16]. These osteogenic properties have also been 
observed in soluble CP materials (e.g. β-tricalcium phosphate, biphasic calcium 
phosphate, CPg, etc.) based on similar mechanisms [5,34]. The advantage regarding 
Bioglass® is that CP are mainly composed by ions highly abundant in the body while 
Bioglass® contains a significant amount of SiO2. Although, it is suspected that the 
release of SiO44- could induce osteogenesis and angiogenesis (formation of blood 
vessels from pre-existing ones) it is not so well understood how this ion is metabolized 
in the body and what are its side effects [4,16,35]. Moreover, some authors maintain that 
osteoclasts are not able to reabsorbed the SiO2 glass network due to its high stability, 
not being this removed from the body [5,16]. On the contrary, CPg are completely 
resorbable by spontaneous degradation. In addition, the amorphous nature of CPg 
results in a homogeneous degradation, minimizing the detachment of small particles with 
possible cytotoxic effects. Some studies have been carried out to evaluate the 
osteogenic properties of different CPg systems with positive results [5,7,23,36,37]. Our 
group have been working with the system 44.5P2O5:44.5CaO:6NaO:5TiO2 (G5) 
observing promising results not only in osteogenesis but also in angiogenesis, as we will 
discuss in section 1.6. [12,20,38]. In one of this studies [38], we supported the Tissue 
Bioengineering department of the University of Bordeaux (France) with the fabrication of 
polylactic acid (PLA) nanofiber scaffolds containing G5 nanoparticles, and 
(hydroxypropyl)methyl cellulose (HPMC) gels containing CPg particles, to test their bone 
regenerative capacity in rat condylar defects. The PLA-G5 fibers function, apart from 
constraining the HPMC gels, was to promote vascularization through the defect. The 
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results were very promising, showing that the presence of the CPg in the HMMC gels 
increased the volume of produced bone and the amount of blood vessels (Figure 5), 
indicating that the resorbable CPg enhanced the consolidation of bone fractures through 
the stimulation of vascularization.  
 
 
 
Figure 5. Micro-CT evaluation of the bone volume (BV) produced A, B) in the rat 
condyle implantation of HPMC gels containing CPg particles (CaP) constricted with 
PLA nanofibers containing CPg nanoparticles. CD31 immunochemistry of histological 
sections showing the presence of blood vessels (arrows) C) and quantification of blood 
vessels density in the histological images D). 540 and 570 refers to the treatment 
temperatures applied to the CPg. For more information please refer to [38]. I did not 
perform the in vivo experiments I assisted with the production and characterization of 
the PLA nanofibers and the CPg nanoparticles. Images adapted from [38] with 
permission. 
C
D
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1.5. Antimicrobial properties 
 
The increased resistance of bacteria against antibiotics due to general abuse is 
generating problems associated with infections not only in orthopaedical surgeries but 
also in other medical interventions [2,39]. On the other hand, the high bioactivity of CP 
materials provides a nice platform for bacterial attachment and spreading [40,41]. 
Therefore, there is a need to develop alternative strategies that avoid bacterial infection. 
Some ions such as Ag+, Cu2+, Ga3+, Zn2+ have demonstrated to have specific 
antimicrobial properties [2,9,10,39,42]. The high affinity of the P2O5 glass network with 
other ions can easily incorporate such antimicrobial cations and introduce a barrier to 
avoid the attachment of microorganisms. Moreover, the high control in the CPg 
degradability allows the possibility of tuning the release of these ions and get 
antimicrobial properties not only during the surgery but also in the post-operatory 
recovery  [42]. The fabrication of biomaterials with antimicrobial properties can increase 
even more their competitiveness due to the reduction of strict and expensive sterilization 
procedures that they have to undergo during the surgery intervention and in the synthesis 
and storage of the material. There are many studies about ceramic CP and silicate 
glasses doped with antimicrobial ions [14,16,39]. However, the relatively young age of 
CPg in the field of biomaterials results in a few research publications about this topic. 
We found few studies that doped CPg with Ag+, Cu2+, F-, and Ga3+ and showed 
antimicrobial properties against several microorganisms [2,9,42,43]. They exhibited 
potential applications not only for orthopaedical surgeries but also in other medical 
interventions like dental health care and the prevention of infections in urinary catheters 
[2]. We are currently working in doping CPg nanoparticles with Zn2+, another 
antimicrobial ion with promising results [39,44]. Interestingly, we introduced for the first 
time Zn2+ in a controlled way in CPg nanoparticles synthesized by the sol-gel method, 
using an own synthesized Zn2+ dialkoxyalkoxide [45]. Although experiments are still on 
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going and the solubility of the particles needs to be further adjusted, preliminary in vitro 
tests showed certain antibacterial properties against Pseudomonas aeruginosa and 
Staphylococcus aureus (Figure 6), two of the main bacteria strains causing infections in 
medical devices [46].  
 
 
Figure 6. Antibacterial properties of CPg nanoparticles containing 10% of Zn2+ against 
Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (S. aureus). Graphs 
show bacterial growth over time when incubated with extracts of the CPg nanoparticles 
incubated at different concentrations in bacteria media. We synthesized the particles 
with the help of Kevin Weise, a master student from Ecole Européenne d’Ingénieurs en 
Génie des Matériaux (EEIGM). Experiments with bacteria were performed by Pep 
Astola from the Bacterial Infections: antimicrobial therapies group (Dr. Eduard Torrents 
group) at the Institute of Bioengineering of Catalonia (IBEC). 
 
A consideration regarding the incorporation of metal ions in the glass is that one must be 
careful with the amount introduced. Slightly low amounts can significantly decrease the 
solubility of the glass minimizing not only the antimicrobial properties but also the own 
bioactivity of the glass. Another aspect to consider is that some of these ions (e.g. Ag+, 
Cu2+) can present acute cytotoxicity at moderately high concentrations [43,47] or in the 
case of Cu2+ be involved in the development of cancer tumors [48,49]. Therefore, their 
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release must be highly controlled. On the contrary, Zn2+ has been reported as beneficial 
in several biological processes like osteoblast proliferation and differentiation, DNA 
synthesis and enzyme activity [39,44], making its use potentially safer for biological  
applications. 
 
 
1.6. Angiogenic potential 
 
Degradable CP materials have demonstrated to favor vascularization [50–52]. However, 
more attention has been focused in decoding their osteogenic potential than the benefits 
in inducing vascularization [53]. Vascularization is usually needed for the regeneration 
of many tissues, including bone. Therefore, it is important to consider its relevance in 
tissue regeneration. Fortunately, there is an increase interest among the research 
community to understand better the mechanisms involved in the formation of blood 
vessels. Blood vessels can grow through two different processes; angiogenesis and 
vasculogenesis [13], being angiogenesis more commonly observed since it involves the 
sprouting of blood vessels from pre-existing ones. For this reason, most of the developed 
strategies to induce vascularization in biomaterials involved angiogenesis [50,51,53]. 
The use of angiogenic factors such as the vascular endothelial growth factor (VEGF) 
seemed very promising since they are the natural chemical cues that the body uses to 
control the spreading of blood vessels. However, the lack of knowledge about their 
involved biology makes the current use of growth factors risky, unpredictable and 
expensive [13,53]. On the other hand, proangiogenic synthetic materials such as CPg 
stimulate the own body to orchestrate the involved mechanisms in the formation of blood 
vessels, reducing the need of using allogenic growth factors or cells. But through what 
mechanisms CPg induced angiogenesis? We recently found that increased loads of CPg 
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nanoparticles in PLA nanofibers increased the subcutaneous formation of blood vessels 
in mice through the action of macrophages (Figure 7) [12].  
 
 
Figure 7. CD31 immunochemistry of histological sections for the subcutaneous 
implantation of PLA nanofibers loaded with different amounts of CPg nanoparticles 
after 1 and 4 weeks (1W, 4W) A), arrows point blood vessels. Blood vessels 
quantification of the histological sections B). I did not perform the in vivo experiments I 
assisted with the production and characterization of the PLA nanofibers and the CPg 
nanoparticles. For more details please refer to [12]. Images adapted from [12] with 
permission. 
 
The causes were not well understood but a controlled local inflammatory response due 
to the scaffold ion release burst during the first stages of implantation could be the 
reason. On the other hand, our group has evidences that specific extracellular Ca2+ 
concentration ranges are able to regulate angiogenesis through the action of cellular 
calcium-sensing receptors (CaSRs). Aguirre et al. observed that the release of certain 
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Ca2+ gradients by a CPg/PLA-scaffold, together with  the mechanical stimulus, induced 
the CaSR regulated synthesis of VEGF by endothelial progenitor cells (EPCs), and 
favored their differentiation into blood vessels (Figure 8) [54].  
 
Figure 8. Scheme illustrating the angiogenic effects of the released Ca2+ and the 
mechanical stimulus of a CPg(Glass)/PLA-scaffold in EPCs. For more details please 
refer to [54]. Image adapted from [54] with permissions. 
 
 
Therefore, controlling the Ca2+ release of CPg over the implantation time could benefit 
the regeneration of tissue through vascularization. However, in the mentioned studies 
the solubility of the CPg was very high when synthesized by the sol-gel method in form 
of nanoparticles [12]. In this thesis, we were focused on sustaining the Ca2+ release of 
CPg nanoparticles synthesized by the sol-gel method and therefore prolonged their 
angiogenic effects. Other alternative strategies to induce vascularization, include the 
incorporation of angiogenic ions to the glass system to give an extra angiogenic potential. 
Among these ions there is Cu2+ or Co2+ with reported angiogenic effects [11,55]. 
However, again their possible biological side effects must be considered as well as the 
produced changes in the solubility of the glass [49,56]. 
G5Glass
Formation of blood vessels
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1.7. Wound healing applications 
 
As we reported in section 1.6., CPg can induce the formation of blood vessels. This 
capacity is not only useful for bone regenerative applications but also for the regeneration 
of softer tissues. Among them, the healing of chronic skin wounds (wound healing) need 
from strategies that favor vascularization [57]. Skin wounds can become chronic due to 
complications associated with infections or disorders in the healing mechanisms due to 
for example diabetes or obesity [58–60]. The result is a poor vascularization in the wound 
site (ischemia) that impairs a normal healing. The current treatments for healing these 
types of wounds are inefficient and patients suffer a high morbidity, pain and sometimes 
amputation is required [61,62]. The angiogenic potential of CPg can introduce benefits 
in the treatment of chronic skin wounds. However, most of the studies about CPg are 
focused in bone regeneration due to their similar composition [5,7,23], not being many 
studies about their use in the healing of soft tissues [13]. Our group has recently 
published the use of a polyethylene glycol (PEG)-based hydrogel containing CPg 
nanoparticles to enhance the survival of implanted mesenchymal stem cells (MSCs) and 
favor the regeneration of soft tissues. In this  study Navarro-Requena et al. [13] 
demonstrated that the presence of the CPg nanoparticles increased the survival of MSCs 
and observed benefits in the promotion of vascularization when implanted in the chick 
chorioallantoic membrane (CAM) (Figure 9) and mice fat tissue. In a parallel 
study, Navarro-Requena et al. also observed that the ions released by a CPg stimulated 
responses on dermal fibroblasts that could favor skin wound healing [63]. Since these 
cells play an essential role in the skin healing process [64], by increasing their potential 
we can accelerate the recovery of hard-to-heal wounds such as chronic skin injuries. 
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Figure 9. Navarro-Requena et al. [13] showing how degradable CPg nanoparticles 
embedded in  methylcellulose (MEC) discs enhanced vascularization in the CAM 
model. Ex-ovo CAM model containing the MEC (Circles) A). Selected images of the 
pure MEC discs (Control) and the MEC discs containing 0.5% or 1% of the CPg 
nanoparticles (GC8 0.5%, GC8 1%) after being 3 days in the CAM model B). 
Quantification of the number of blood vessels converging towards the MEC discs in the 
CAM images C). GC8 refers to a CPg containing 8% of Ti4+. Image adapted from [13] 
with permission.   
 
Going further, we have already demonstrated (paper under development), that PLA 
nanofiber dressings containing degradable CPg nanoparticles significantly increased the 
healing of ischemic cutaneous wounds in diabetic and obese mice in comparison to 
conventional Mepilex® dressings, already used in the clinics to treat these types of 
wounds. In this study (which I supported with the fabrication and characterization of the 
PLA-CPg dressings), Perez-Amodio et al. correlated the mentioned improvements with 
an increase in the vascularization at early stages of the healing, and with a higher 
fibroblast activity, both attributed to the Ca2+ released by the degradation of the 
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dressings. However, in this thesis we considered that the simultaneous release of 
inorganic phosphate (Pi) could also induce the calcification of the wound site, which 
would not be ideal for the healing of soft tissues [64]. For this reason, we avoided the 
presence of Pi in the glass system and synthesized pure Ca2+ containing degradable 
nanoparticles for wound healing applications. 
 
 
1.8. Scaffolds manufacturing techniques  
 
The development of synthetic scaffolds have a great potential for biomedical applications 
since there is the possibility to avoid the use of drugs or biological components (e.g. 
growth factors, cells) with strict regulations to reach the market [65,66]. Moreover, the 
current manufacturing technologies allow a high control over the scaffold morphology 
and properties. CPg, although being less stiff than crystalline CP ceramics [5], easily 
break under stress and often need to be combined with a tougher matrix to create a 
composite with more flexibility and higher shape control [19,67,68]. The matrix is usually 
a biodegradable polymer from a natural (e.g. collage, alginate, gelatin) or synthetic origin. 
Synthetic biodegradable polymers are usually less bioactive, but they possess better 
mechanical properties and have less variability once implanted due to they do not 
undergo enzymatic degradation [69]. Among synthetic polymers, polylactic acid (PLA) 
have an interesting degradability rate between the more stable polycaprolactone (PCL) 
and the highly degradable polyglycolic acid (PGA) [69]. Moreover, the released L-lactate 
due to its degradation, apart from being metabolized in the Krebs cycle [69], has 
demonstrated to be angiogenic [70,71]. Among polymer manufacturing technics for 
biomedical scaffolds, we can highlight; solvent-casting, 3D printing and electrospinning 
technique. Most of them consist of dissolving or sintering the polymer to cast a certain 
shape. 3D printing has the highest control over the scaffold morphology, allowing to build 
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macro and microstructures with specific geometry. In the case of solvent-casting, soluble 
particles (i.e. porogen) can be introduced in the polymer solution to introduce porosity to 
the manufactured scaffold [50]. On the other hand, the electrospinning technique is 
nowadays the cheapest way to mimic the morphology of the extracellular matrix (ECM) 
collagen fibrils and achieve scaffolds with the highest surface-to-volume ration [72]. 
Since in this thesis we chose the electrospinning technique to fabricate the scaffolds, we 
will discuss it further in this section. 
 
Figure 10. Scheme illustrating the electrospinning procedure. Image from [73] with 
permission.   
 
The electrospinning technique consist of applying a high voltage into a polymer solution 
to achieve nanofibers of the polymer in question (Figure 10) [74]. When the repulsion 
between the dissolved polymer chains overcomes the solution surface tension a jet is 
projected against a grounded collector. The solvent from the jet is evaporated due to the 
high voltage, leaving solid nanofibers of the polymer. Using rotatory collectors or coaxial 
syringe tips, one can achieve aligned or core-shell polymer fibers respectively [74]. The 
CPg in form of nanoparticles can be easily dispersed into the polymer solution before 
electrospinning, as we did in several studies [12,38], to create a  composite of PLA 
nanofibers with improved mechanical properties and bioactivity (Figure 11A). However, 
in order to reinforce the interaction polymer-CPg and expose the bioactive CPg onto the 
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0.5 µm 
B) A) 
surface of the fibers, we have developed alternative methods of fabrication. These 
methods consisted of mixing the partially hydrolyzed CPg sol-gel precursors with the 
polymer solution before electrospinning or covalently attach the CPg nanoparticles onto 
the already electrospun polymer nanofibers surface (Figure 11B,11C) [20,21]. These two 
approaches have given promising results. For instance, CPg blended fibers increased 
the mice subcutaneous formation of blood vessels [20], and Si-CPg coated fibers 
induced a higher cell adhesion in comparison to pure PLA nanofibers [21]. 
 
 
 
 
 
 
 
Figure 11. PLA nanofibers containing embedded CPg nanoparticles [12] A). PLA 
nanofibers blended with the partially hydrolyzed CPg sol-gel precursors [20] B). PLA 
nanofibers covalently coated with Si-CPg nanoparticles using the EDC/NHS surface 
treatment and the APTES coupling agent  [21] C). Images from [12,20,21] with 
permission.   
 
One of the research lines in which I was involved consisted of covalently coat the PLA 
nanofibers with the new developed CPg nanoparticles, using the 1-ethyl-3-(-3-
dimethylaminopropyl)carbodiimide/N-hydroxysuccinimide (EDC/NHS) activation method 
and the (3-aminopropyl)triethoxysilane (APTES) coupling agent [21]. However, problems 
regarding steric effects difficulted the attachment of the particles, whose were finally 
embedded inside the PLA nanofibers by conventional methods (Figure 11A). On the 
other hand, pure CPg scaffolds without a polymer matrix can be also conformed into 
different shapes by sintering or melting techniques. It is possible to introduce porosity to 
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these scaffolds by the infusion of a gas, creating a foam [7]. However, crystalline and 
brittle structures are usually obtained. Pure CPg fibers have been also produced for 
biomedical applications following sophisticated laser techniques [2]. The high length-to-
diameter fiber ratio conferred a unique flexibility reducing the brittleness of the scaffold. 
However, in aqueous solutions these fibers broke easily due to the formation of 
polycrystalline structures [2,75]. In this thesis, we used the electrospinning technique to 
create implantable composite scaffolds of PLA nanofibers with embedded CPg 
nanoparticles that mimicked the natural ECM. The high surface area achieved by this 
technique was chosen to increase the scaffold degradability and ion release.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
1.9. Conclusions 
 
CPg offer a unique platform for temporary tissue substitutes. Their high control over their 
composition and solubility adapts their use for different biomedical applications. Among 
manufacturing techniques, the sol-gel method allows the possibility to nanostructure the 
glass into nanoparticles. The sol-gel method also allows the possibility to incorporate 
extra ions to the glass structure to tune their properties and confer specific bioactivity 
(e.g. antimicrobial, angiogenesis). NMR spectroscopy is among the most used 
techniques to characterize CPg due to their amorphous nature, nevertheless, it needs 
from the complementation of other techniques like X-ray diffraction or FTIR 
spectroscopy. Many applications of CPg have been focused in bone regeneration due to 
their similar composition and ability to be strongly attached. However, their angiogenic 
potential, in which their Ca2+ release plays an important role, also suggests their use in 
the regeneration of highly vascularized softer tissues like chronic skin wounds. The 
brittleness of CPg makes necessary their combination with tougher biodegradable 
polymers to create implantable scaffolds. In this case, the electrospinning technique 
offers the possibility to create nanofiber composites that mimic the morphology of the 
extracellular matrix. Among biodegradable polymers, PLA have demonstrated to 
stimulate angiogenesis due to the release of L-lactate by its degradation. However, in 
this thesis, we will focus on controlling the Ca2+ release of CPg nanoparticles synthesized 
by the sol-gel method to improve angiogenesis. We will create composite scaffolds 
combining the CPg nanoparticles with electrospun PLA nanofibers, and finally, we will 
study the angiogenic potential of the scaffolds for bone and wound healing applications.  
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Chapter 2. First sol-gel synthesis of 
binary (P2O5-CaO) calcium 
phosphate glass nanoparticles with 
controlled bioactive degradation 
 
 
 
Scheme summarizing the content of the chapter 
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In this chapter we reported the first systematic sol-gel synthesis of binary (P2O5-CaO) 
calcium phosphate glasses (CPg) nanoparticles. We highlight “systematic” because only 
the strict control of the experimental conditions and the generated knowledge in the 
fundamental characterization of the transition sol-gel/solid allowed us to obtain this 
important and reproducible milestone. The study of binary CPg for biomedical 
applications is of interest due to their straightforward synthesis, lack of unnatural-body 
ions (e.g. SiO44-, Ti4+), and increase of bioactive release of Ca2+ and inorganic phosphate 
(Pi) ions. CPg nanoparticles with different Ca/P ratios were synthesized by combining 
ethylphosphate and calcium 2-methoxyethoxide. We applied a moderately low thermal 
treatment at 200 or 350 °C to stabilize the solubility of the particles in physiological 
conditions. The reaction between the two precursors and the formation of the particles 
was studied by NMR spectroscopy and other complementary techniques. We also 
measured the ion release (Ca2+ and Pi) and pH modifications when the particles were 
immersed in buffered aqueous medium. Before thermal treatment, we achieved highly 
soluble particles due to the formation of calcium monoethylphosphate. After thermal 
treatment, the ion release was sustained due to the elimination of ethoxides and the 
condensation of phosphates. We developed a cost-effective and feasible CPg platform 
to adjust different ion release profiles to fulfil different biological demands for tissue 
regeneration like for example angiogenesis, osteogenesis or wound healing. 
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2.1. Introduction 
 
CPg synthesized by the sol-gel method are gaining importance in the field of tissue 
engineering especially in bone regeneration [1]. Their low temperature synthesis, in 
contrast to melt-quenched glasses, minimizes atom diffusion and sintering, allowing an 
outstanding control over their micro/nanostructure [2,3]. Several studies have focused in 
synthesizing different nanostructured CPg systems combining Pi and Ca2+ with other 
ions (e.g. Na+, Ti4+, SiO44-) to achieve different properties and degradability [3–5]. 
However, the use of multicomponent systems hinders their synthesis and introduces ions 
whose metabolization is still not fully understood [6–8]. In this study, we wanted to 
develop binary (P2O5-CaO) CPg nanoparticles containing only Ca2+ and Pi due to their 
known biocompatibility. We tailored their degradability by modifying their Ca/P ratio and 
applying moderately low thermal treatment temperatures. The degradation of such 
materials in the body are able to trigger several bioactive responses. For example, it is 
known that the release of Ca2+ and Pi, participates in bone mineralization and 
osteogenesis [9,10]. On the other hand, Ca2+ also participate in many other cell metabolic 
processes such as chemotaxis and cell proliferation [9], and recently we found evidences 
that certain Ca2+ mM concentrations stimulate angiogenesis [2,3,11]. We chose to 
synthesize the CPg in the form of nanoparticles for an straightforward combination with 
other nanoconstructions (e.g. biodegradable polymer scaffolds) [3,10] and thus achieve 
biomedical devices with specific micro/nanofeatures. We synthesized the CPg 
nanoparticles by the sol-gel method using a mixture of mono/diethylphosphate 
(MEP/DEP) and calcium 2-methoxyethoxide (CMEO) (Scheme 1). These two sol-gel 
precursors have shown a suitable compatibility, resulting in the synthesis of CPg with a 
homogeneous composition [3,5]. We applied a moderately low thermal treatment (200 
or 350 °C) to eliminate the organic material and stabilize the physiological solubility of 
the particles. The reaction between the two precursors and the characterization of the 
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particles, before and after thermal treatment, was studied by NMR spectroscopy (1H 
NMR, 31P NMR and 31P MAS NMR) and other complementary techniques such as ESI-
MS, X-ray diffraction (XRD), ATR-FTIR, EDS, elemental analysis (EA), DLS and FE-
SEM. Finally, we measured the ion release (i.e. Ca2+ and Pi) and pH modification of the 
particles, before and after thermal treatment, in a 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffered solution (pH 7.4) at 37 ºC, that 
mimicked the physiological conditions of the body. 
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2.2. Materials and methods 
 
If not otherwise specified all reagent were purchased from Sigma-Aldrich. 
 
2.2.1. Sol-gel precursors synthesis 
 
P and Ca precursors were synthesized as previously published [3,12]. Briefly, 
phosphorus pentoxide (≥99,99%) and metallic calcium granules PS (98%, Panreac) 
were dissolved in distilled absolute ethanol PRS (99,5%, Panreac) and anhydrous 2-
methoxyethanol (99,8%) respectively. After refluxing them at the solvent boiling point 
under Ar(g) atmosphere for 12 and 24 h respectively, we obtained 4 M ethylphosphate in 
ethanol and 1 M calcium 2-methoxyethoxide in 2-methoxyethanol. The solutions were 
filtered using 0.45 µm PTFE hydrophobic Minisart® SRP25 syringe filters (Sartorius AG, 
Göttingen, Germany) and stored under Ar(g) at -20 °C. 
 
2.2.2. CPg nanoparticles synthesis 
 
The CPg nanoparticles were synthesized by mixing different ratios (10:0, 8.5:1.5, 6:4, 
1.5:8.5 and 0:10 mL) of the P and Ca precursors respectively, in 90 mL of absolute 
ethanol (PRS, 99,5%, Panreac). Ammonia (PA-ACS, 30%, Panreac) was added 
dropwise under vigorous stirring until a suspension of particles was observed. After 12 h 
the particles were centrifuged, cleaned twice with absolute ethanol, once with hexane 
(ACS, ≥99%) and dried at 70 ºC for 2 h. Dried particles were ground and stored in a 
desiccator under vacuum. Then the particles were heated for 12 h at 200 or 350 ºC in a 
muffle furnace L9/11 (Nabertherm, Lilienthal, Germany) and stored in a desiccator under 
vacuum. Before and after thermal treatment, the particles were weighed in a Sartorius 
CP224S analytical balance (Sartorius AG, Göttingen, Germany) to know yields and mass 
loss. 
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2.2.3. 1H and 31P NMR spectroscopy 
 
1H and 31P NMR of the two alkoxides in anhydrous ethanol-d6 (≥99,6%) and the 
dissolved particles (5 mg/mL) in D2O (99.9%) plus 1.5% HCl (37%, Panreac), were 
performed at room temperature using a Bruker 400 MHz Avance III spectrometer 
(Bruker, Billerica, MA, USA) equipped with a Prodigy TCl 5 mm cryoprobe. 1H NMR 
spectra were recorded between 16 and -3.8 ppm, applying 3.66 µs, 30° pulse, a delay 
of 1 s between pulses, and an acquisition time of 2.5 s. 32 scans were accumulated to 
have a good signal-to-noise ratio. Spectra were referenced to the 1H of the deuterium 
solvent. 31P NMR spectra were registered between 250 and -250 ppm, applying 3.76 µs, 
30° pulse, a delay of 1 s between pulses, and an acquisition time of 1.6 s. 256 scans 
were accumulated to have a good signal-to-noise ratio. Spectra were externally 
referenced to H3PO4 (85%). 1H was decoupled during 31P NMR spectrum acquisition. 
Data were analyzed with the ACD/Spectrus Processor software [13]. The ethanol 
(solvent) of the phosphorus precursor was evaporated prior to analysis using a vacuum 
pump to better resolve possible hydrolysis or condensation of the ethylphosphate. 
 
2.2.4. Electrospray ionization mass spectrometry (ESI-MS) 
 
The 1 M calcium 2-methoxyethoxide was dissolved 104 times in absolute ethanol (PRS, 
99.5%, Panreac) and analyzed on a ThermoFinnigan LTQ ion trap mass spectrometer 
(Thermo Fischer Scientific, Waltham, MA, USA), with sample introduction by direct 
infusion at 3 µL/min. The full mass spectrum scan was recorded in the mass range of 
m/z 50-650 using positive ion polarity.  Instrument parameters included spray voltage: 
3.5 kV, capillary temperature: 200 °C, capillary voltage: 75 V, and tube lens voltage: 100 
V. Mass spectra were acquired by the University of Kentucky Mass Spectrometry Facility. 
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2.2.5. Dynamic Light Scattering (DLS) 
 
The P and Ca precursors were dissolved (a few drops) separately and together in 1 mL 
of absolute ethanol (PRS, 99.5%, Panreac). The solutions were measured in a Zetasizer 
Nano ZS (Malvern, Worcestershire, UK) using a 10x2 mm precision Quartz Suprasil® 
cell 115F-QS (Hellma®Analytics, Müllheim, Germany). Results were analyzed using the 
Zetasizer software version 7.12 (07/12/2016) (Malvern, Worcestershire, UK) for 
Windows 7. Size population was expressed in volume percentage. 
 
2.2.6. Particle composition and morphological images (EDS/FE-SEM) 
 
A Quanta Q200 scanning electron microscope (SEM) (FEI Company, Hillsboro, OR, 
USA) coupled with an energy dispersive X-ray spectroscopy detector (EDS) was used 
at 20.0 KV and 10 mm of working distance to quantify the approximate P and Ca atomic 
ratio of the particles. Values express the average of at least three different 
measurements. For morphological images, we used the NOVA NanoSEM-230 ultrahigh-
resolution field emission scanning electron microscope (FE-SEM) (FEI Company, 
Hillsboro, OR, USA) at 5.00 KV and 5.0 mm of working distance. In both cases, samples 
were coated with a thin carbon layer to improve conductivity. For morphological images, 
approximately 1 mg of the particles was dispersed in 1 mL of absolute ethanol PRS 
(99,5%, Panreac) and sonicated for several seconds with an Ultrasonic Processor 
UP50H (Hielscher Ultrasonics, Teltow, Germany) for a better particle dispersion. 2 µL of 
the dispersion were added on silicon substrates and left to dry at room temperature (RT).   
 
2.2.7 Elemental analysis (EA) 
 
Approximately, 2000 µg of each particles were weighed in a MX5 microbalance (Mettler-
Toledo, Greifensee, Switzerland). The samples were analyzed by combustion at 1060 
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ºC in an elemental analyzer EA CE 1108 (Thermo Fischer Scientific, Waltham, MA, USA) 
to determine the mass percentage of C and N. A mixture of vanadium pentoxide and 
lead powder was added to facilitate combustion. Atropine was used as a standard.   
 
2.2.8. X-ray diffraction (XRD) 
 
The particles were manually pressed in a cylindrical standard sample holder of 16 mm 
of diameter and 2.5 mm of height, using a glass plate to get a flat surface. Samples were 
analyzed using a PANalytical X’Pert PRO MPD Alpha1 Powder Diffractometer 
(PANalytical, Almelo, the Netherlands) in a Bragg-Brentano /2 geometry of 240 mm of 
radius. The spectra were interpreted using the software ©PANalytical X’Pert HighScore 
(PANalytical, Almelo, the Netherlands) and the database PDF2 (2001) from the 
international center of diffraction data (ICDD). 
 
2.2.9. 31P MAS NMR spectroscopy 
 
31P MAS NMR spectra were performed in a Bruker 400 MHz-WB Avance-II spectrometer 
(Bruker, Billerica, MA, USA), externally referenced to H3PO4 (85%). Approximately 50 
mg of the particles were placed in a ZrO2 4 mm rotor and spun at 12 kHz. The HPDEC.AV 
standard pulse sequence was used to run the experiments with a 5 µs pulse length 
corresponding to a 90° tip angle and the recovery delay was set to 5 s. A total of 512 
scans were accumulated for each spectrum to have a good signal-to-noise ratio. 1H was 
decoupled using a Spinal-64 scheme (at 73 watts power level). Data was processed 
applying a FT exponential function (line broadening, lb 15 Hz).   
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2.2.10. Attenuated total reflectance infrared spectroscopy (ATR-FTIR) 
 
Approximately 5 mg of the particles were pressed in a Spectrum Two FT-IR 
Spectrometer (PerkinElmer, Waltham, MA, USA) coupled with an UATR Diamond/ZnSe 
accessory (1 reflection). A background without particles was taken before each 
measurement. Spectra were analyzed using the software ©PerkinElmer Spectrum 
(PerkinElmer, Waltham, MA, USA) and the database ©2005-2008, Fiveash Data 
Management, Inc. 
 
2.2.11. Ion release and pH measurements 
 
3 mg of each particle (three replicates per condition) were placed in 1.5 mL 
microcentrifuge tubes. 1.3 mL of 0.05 M 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic 
acid (HEPES) (99,5%) in miliQ-water at pH=7.4 was added to each tube. Tubes were 
placed in a Memmert incubator (Memmert Gmbh + Co KG, Schwabach, Germany) at 37 
°C with gentle agitation. At 1 h, day 1, 3, 6, 9 and 14, tubes were centrifuged at 8000 
rpm for 6 minutes and 1.1 mL of each media was extracted. Another 1.1 mL of 0.05 M 
HEPES solution was added to each tube and the particles were gently resuspended 
using a vortex mixer. Tubes were incubated again at 37 °C. The extracted media were 
frozen at -20 °C until further analysis. The pH of each extraction was measured using a 
Crison 50 28 pH electrode and a Crison pH-Meter GLP 22+ (Hach Company, Loveland, 
CO, USA) previously calibrated with 4.01, 7.00 and 9.21 pH standard solutions. The Ca2+ 
content of the extracts was measured using a colorimetric method based on the O-
Cresolphthalein complexone [14,15]. Briefly, 4 µL of the extractions were added to 80 µL 
of 1.5 M 2-amino-2-methyl-1-propanol (AMP) (≥90%) aqueous solution with HCl (37%, 
Panreac) to maintain the pH at 10.4. Then 80 µL of 0.16 mM O-Cresolphthalein, 6.8 mM 
8-Hydroxyquinoline (99%) and 1.19 M HCl (37%, Panreac) aqueous solution was added. 
The reaction between the Ca2+ and the O-Cresolphthalein produced a purple complex 
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that was measured by absorbance at 570 nm. A calibration curve (7.5, 5, 2, 1, 0.5, 0.1, 
0 mM) of CaCl2 ion solution for ion-selective electrodes (0.1 M) was prepared to convert 
absorbances to Ca2+ concentrations. The Pi content of the extracts was measured using 
the Phosphate Colorimetric Kit based on the malachite green method [16]. A calibration 
curve of PO43- (25, 20, 15, 10, 5, 0 µM) was prepared from a 10 mM phosphate standard 
solution (included in the kit) to convert absorbance to Pi concentrations. The absorbance 
was measured at 650 nm wavelength. All absorbances were measured in an Infinite 
M200 Pro Microplate Reader (Tecan Group Ltd., Männedorf, Zürich, Switzerland). 
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2.3. Results and discussion 
 
 
Scheme 1. Scheme of the Mono-, Di- and Tri-ethylphosphate (MEP, DEP and TEP), 
and the calcium 2-methoxyethoxide (CMEO). 
 
 
2.3.1. Phosphorus (P) precursor characterization 
 
We characterized the P precursor by 1H and 31P NMR spectroscopy (Figure 1). Being 
consistent with Ali et al. [17], we identified the formation of monoethylphosphate (MEP) 
and diethylphosphate (DEP) with traces of triethylphosphate (TEP) and H3PO4. The 1H 
NMR spectrum (Figure 1A) showed two overlapped triplets centered at 1.3 ppm that 
represents the methyl groups (-CH3) of the MEP and DEP respectively. The splitting of 
each peak in two refers to the coupling with the 31P nuclei (J41H-31P) and demonstrates 
that the -CH3 were part of ethylphosphate molecules. The multiplet centered at 4.07 ppm 
refers to the methylene bridges (-CH2-), and it is the result of the overlapping of two 
quadruplets associated to the MEP and DEP respectively. Again, each quadruplet is split 
in two due to the coupling with the 31P nuclei. 
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Figure 1. 1H NMR A) and 31P NMR B) spectra of the P precursor. Integrated intensities 
of the 1H and 31P NMR spectra C). To compare 1H and 31P NMR integrated intensities, 
the 31P NMR ones need to be multiplied by the number of ethoxides. Notice that the 31P 
NMR integrated intensities contained a certain error due to the decoupling with the 1H 
nuclei. Percentages in B) were calculated using the integrated intensities from C). 
 
The 31P NMR spectrum (Figure 1B) of the P precursor showed the presence of two high 
abundant 31P compounds, and traces of another two. 1H and 31P NMR integrated 
intensities (Figure 1C) indicates that the MEP was the most abundant compound 
followed by the DEP. The two less abundant compounds were associated to the TEP 
and H3PO4. We used the 1H NMR integrated intensities to quantify the relative 
abundance of the MEP, DEP and TEP, and the 31P NMR ones to quantify the H3PO4. 
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Notice that the 31P NMR integrated intensities contained a certain error due to the 
decoupling with the 1H nuclei.   
 
 
2.3.2. Calcium (Ca) precursor characterization 
 
The 1H NMR spectrum of the Ca precursor showed two broad triplets and one broad 
singlet, associated to the -CH2- and -CH3 of the calcium 2-methoxyetoxide (CMEO) 
respectively (Figure 2A). It has been reported this broadening effect for Ca2+ organic 
complexes due to the coordination of the oxygen atoms to a metallic center [18]. Unlike 
the P precursor (Figure 1C), here we could not differentiate between the CMEO and the 
solvent 2-methoxyethanol (MEOH). The addition of MEOH sharpened and shifted the 1H 
NMR peaks instead of adding a new signal. The fast exchange CMEO/MEOH due to the 
ionic interaction Ca2+/MEO- could be the reason of observing the same signals for the 
two compounds [19]. To better elucidate the Ca precursor structure, we complemented 
the NMR analysis with mass spectrometry. The ESI-MS spectra (Figure 2B) revealed the 
formation of highly stable [Ca(MEOH)3]2+ and [Ca(MEOH)4]2+ complexes. These two 
complexes are consistent with the identification of hexa- and heptavalent calcium 
domains for the single crystal characterization of CMEO [20]. In such study [20] Goel et 
al.  defined the formation of a bigger [Ca9(MEO)18(MEOH)2] cluster than those observed 
in the ESI-MAS spectrum. However, the DLS measurements of the Ca precursor (Figure 
2C) showed an average complex size of ~5 nm, suggesting the formation of such big 
cluster in solution and that the ESI-MS measurement conditions disrupted it into smaller 
subunits. A relevant observation about the Ca precursor is its dark-orange color (Figure 
2D). Electronic orbital transition energies between metal ions and alkoxides can result in 
the emission of certain colors. It has been described that the ligand-metal charge transfer 
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drives the orbital transitions into energies that absorb and emit at different wavelengths 
[21–23], which would explain the observed dark-orange color. 
 
 
 
 
 
 
 
 
 
Figure 2. 1H NMR spectra of the Ca precursor before (CMEO) and after the addition of 
MEOH (CMEO+MEOH) A). ESI-MAS analysis B) and DLS measurements C) of the Ca 
precursor. Picture showing the dark-orange color of the Ca precursor D). 
 
 
2.3.3. P and Ca precursors interaction  
 
We observed by 1H and 31P NMR spectroscopy (Figure 3A, 3B) a peak broadening and 
shielding of the MEP and DEP signals when the two precursors were mixed together 
(P+Ca). On the other hand, the peaks of the TEP remained unaltered and the ones from 
the CMEO became sharper (Figure 3C). All together indicates that the Ca2+ were 
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interacting with the free hydroxyl groups of the ethylphosphate molecules, forming a new 
complex. 
 
 
 
Figure 3. 1H A) and 31P B) NMR spectra of the P precursor, before (P) and after the 
addition of the Ca precursor (P+Ca), and the supernatant after the precipitation of 
particles by the addition of NH3(aq) (P+Ca+NH3). 1H NMR spectrum of the Ca precursor 
before (Ca) and after the addition of the P precursor (Ca+P) C). Notice that the EtOH of 
Ca+P in C) came from the absence of P precursor purification in this specific analysis 
(section 2.2.3.). 1H NMR integrated intensities of the P precursor (P) and the 
supernatant P+Ca+NH3 D).  
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DLS measurements supported the previous results, showing the disruption of the CMEO 
complex at ~5 nm and presenting a new one at ~1.8 nm (Figure 4A). We observed that 
the size of this new complex increased over time until the formation of particles or 
aggregates of ~1 µm after 30 h (Figure 4B). The addition of ammonia (NH3(aq)) 
accelerated and increased the precipitation of particles. Integrated 1H NMR intensities 
(Figure 3D) of the supernatant (P+Ca+NH3) after the precipitation of particles by the 
addition of NH3(aq), showed the sole presence of DEP and TEP, indicating that only the 
MEP and the H3PO4 were incorporated into the particles. The lack of increase in the 
ethanol signal (Figure 3D) indicates the absence of hydrolysis or condensation of the 
ethylphosphates and the incorporation of the ethoxide groups into the particles. 
 
 
 
 
 
Figure 4. DLS measurements of the P and Ca precursors separately and together A). 
P+Ca complex size evolution over time B). 
 
2.3.4. Precipitation of CPg nanoparticles 
 
We synthesized particles with different P/Ca atomic ratios using different proportions of 
the P and Ca precursors (Table 1, 2). The particles were coded depending on their P 
content in ratio to the Ca one. We achieved particles with P contents ranging from 100% 
to 0%. Surprisingly, we needed huge volumes of the P precursor to obtain particles with 
 
                                              
2
             
                  
  
 
 
   
                                                
             
 ) 
   
   
2  
   
  
 
                                              
2
             
                  
  
 
 
   
                                               
     2                                 
   
   
   
2  
  
B) 
   
55 
 
P>55%. The low mass yields for the P>55% particles suggest that their precipitation in 
an ethanolic environment was hindered. Regarding the amount of NH3(aq) used, we 
needed significantly smaller proportions to synthesize P100 and P65 particles, and, 
surprisingly, P55 particles were achieved by spontaneous precipitation. This indicates 
that the particles with P≥55% precipitated at lower alkaline conditions. Before thermal 
treatment, the particles contained a high amount of carbon (C), increasing this one with 
the P content. This was consistent with the incorporation of MEP into the particles (Figure 
3D). After thermal treatment, the C content and the weight of the particles significantly 
decreased, suggesting the decomposition of the ethoxide groups. However, P30 and P0 
particles maintained a significant C amount with a mass increase for P0 after thermal 
treatment. Before thermal treatment, The P100 particles contained a high N amount, 
suggesting the formation of ammonium phosphate salts. The P/Ca ratio of the particles 
was practically the same after thermal treatment, showing the absence of phosphate 
decomposition at such temperatures [24]. On the other hand, the P100 particles 
decomposed to a brown paste at 200 ºC.  
Table 1. Particle synthesis conditions, yields and mass loss after thermal treatment. 
  
P:Ca 
precursors 
(mL) 
EtOH:NH3(aq):H2O 
(mL) 
Yield 
(mg) 
Mass loss (%) 
P100  10:0   90:1.7:10 127 Decomposed (200 °C) 
P65  8.5:1.5  90:1.9:6 359  -26.9 (200 °C) 
P55  4:6  90:0:0 718  -25.96 (200 °C) 
P30  1.5:8.5  90:30:0 948  -23.24 (350 °C) 
P0  0:10  90:30:0 781  +19.59 (350 °C) 
 
 
Table 2. Particle composition before A) and after thermal treatment B). P/Ca atomic % 
measured by EDS. C and N mass % measured by EA. 
A) 
P/Ca       
(atomic %) 
C          
(mass %) 
N         
(mass %) 
 
B) 
P/Ca          
(atomic %) 
C            
(mass %) 
N             
(mass %) 
P100 100/0 0.80 12.63  200°C Decomp. - - 
P65 63.9/36.1 17.13 ≤0.2  200°C 62.9/37.1 0.34 ≤0.2 
P55 54.1/45.9 15.81 ≤0.2 
 
200°C 56.5/43.5 0.37 ≤0.2 
P30 28.7/71.3 9.77 ≤0.2  350°C 29.8/70.2 5.66 ≤0.2 
P0 0/100 3.15 ≤0.2  350°C 0/100 7.74 ≤0.2 
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Figure 5. FE-SEM images of the particles before A) and after thermal treatment B). 
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FE-SEM images of the particles (Figure 5) showed aggregates ranging from several 
hundreds of nm to few µm. The aggregates seemed to be composed by smaller particles 
of few nm in size. The formation of aggregates suggests a low particle electrostatic 
repulsion, attributed to small surface Z-potentials. All compositions showed a spherical-
like shape except for P65 and P55 particles whose morphology resembled to those of 
faceting-like structures. After thermal treatment, all compositions had a similar spherical-
like shape. We did not observe significant changes in the aggregate size for the different 
compositions before and after thermal treatment. 
 
 
2.3.5. CPg nanoparticles characterization 
 
2.3.5.1. X-ray diffraction analysis 
 
X-ray diffraction showed the formation of portlandite for P30 and P0 particles (Figure 
6A). This indicates that existed a Ca excess for the particles with P≤30% that precipitated 
in form of Ca(OH)2. On the other hand, we observed the formation of crystalline 
NH4H2PO4 for P100 particles, which was consistent with the N detected in the EA 
analysis (Table 2A). That shows up that in the absence of Ca2+, the NH3(aq) added to 
precipitate the particles was incorporated as a counterion. Separately, we detected for 
P30, P55 and P65 particles an unidentified peak (marked with a star) at the left side of 
the spectrum. The increase of this peak intensity with the P content suggests that it might 
be related to some crystalline diffraction plane of calcium MEP, since we identified by 1H 
NMR spectroscopy the sole incorporation of MEP (with a small amount of H3PO4) in the 
particles (Figure 3D). 
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Figure 6. X-ray diffraction spectra of the particles before A) and after thermal treatment 
B). 
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After thermal treatment (Figure 6B), we observed the carbonatation of the portlandite of 
the P30 and P0 particles to calcite. Although there were still traces of portlandite in the 
P0 particles, a minimum temperature of 350 ºC was enough for most of the conversion. 
The formation of calcite (CaCO3) justifies the high amount of C detected for P30 and P0 
particles in the EA analysis (Table 2B). As previously mentioned, we inferred that P100 
particles probably decomposed to NH3(g) and H3PO4(l) at 200 ºC. We observed a complete 
amorphous structure for P55 and P65 particles, suggesting the formation of CPg phases 
[25–27]. The unidentified peak (marked with a star), which we attributed to calcium MEP, 
was not observed anymore, being consistent with the decomposition of ethoxides at 200 
ºC (Table 2B). We would like to highlight that the presence of P by EDS (Table 2B) and 
the absence of CP crystalline structures [24,28–30] before and after thermal treatment, 
indicates the existence of amorphous CP compounds for all the particles containing P.   
 
 
2.3.5.2. 31P MAS NMR spectroscopy 
 
The 31P MAS NMR spectra of the particles before thermal treatment showed the sole 
presence of orthophosphate (Q0) units (Figure 7A) [4]. The only detection of Ca and P 
by EDS (Table 1) lead us to the conclusion that these orthophosphates were in form of 
CP. The peaks were narrow indicating a high mobility of the 31P nucleus. This high 
mobility is commonly observed in crystalline CP structures [31]. However, we did not 
identify any crystalline CP phase in the X-ray diffraction spectra (Figure 6A). We 
hypothesize that the existence of ethoxide groups disrupted the CP crystalline periodicity 
but still allowed a high nuclei mobility. On the other hand, the P55 particles showed 
significant wider peaks, distinctive of chemical structures with low mobility and high 
connectivity, like amorphous ones [4,31]. Returning to the X-ray diffraction spectra 
60 
 
(Figure 6A), we observed that the P55 particles had an amorphous pattern. The 
spontaneous precipitation of P55 particles without the addition of NH3(aq) in the synthesis 
process (Table 1), may have affected somehow in the CP structure. Another possibility 
is that the absence of well-ordered structures like portlandite or NH4H2PO4 in the particles 
(Figure 6A) had also an effect on the amorphicity of the CP phase.  
 
 
Figure 7. 31P MAS NMR spectra of the particles before A) and after thermal treatment 
B). Relative peak abundance and chemical shifts in Table 3. 
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Table 3. 31P MAS NMR (Figure 7) chemical shifts, peak assignment and relative 
abundance of the particles before A) and after the thermal treatment B). 
 
 
In addition, we identified in the 31P MAS NMR spectra (Figure 7A) a small amount of 
pyrophosphates (Q1) for the P55 particles [24]. This small phosphate condensation 
probably affected in the amorphicity of the particles since condensed phosphate units 
will tend to decrease atomic mobility.  
After thermal treatment, we observed the formation of Q1 and Q2 units increasing those 
with the P content of the particles (Figure 7B) [4,32]. We also observed wide peaks 
characteristic of amorphous structures. The Q1 units for the P30 particles were assigned 
to pyrophosphates, however, the presence of Q2 units for the P55 particles, indicates the 
formation of metaphosphates [24]. The high amount of Q1 units for P55 particles 
suggests that the metaphosphates were in form of open-chained trimetaphosphates 
[32,33]. All together indicates that a thermal treatment at 200 ºC was enough to induce 
the condensation of the orthophosphate units. We hypothesized that the presence of 
ethoxides may have favored such condensation. It is evident that the amount of Ca2+ 
difficulted the phosphate condensation due to the good affinity of Ca2+ with the phosphate 
oxygen atoms. Surprisingly, P65 particles showed narrower peaks and a less phosphate 
B)
Chemical 
shift (ppm)
Assignment
Relative 
abundance 
(%)
P65-
200 C
-0.22 Q0 13.90
-4.67 Q0 35.29
-10.92 Q1 39.18
-15.85 Q1/Q2 11.62
P55-
200 C
-1.31 Q0 14.74
-9.89 Q1 74.35
-23.05 Q2 10.91
P30-
350 C
2.89 Q0 68.64
-8.05 Q1 31.36
A)
Chemical 
shift (ppm)
Assignment
Relative 
abundance 
(%)
P100-
RT
0.64 Q0 76.26
-0.52 Q0 23.74
P65-
RT
2.27 Q0 8.41
1.06 Q0 11.26
-1.83 Q0 80.33
P55-
RT
-3.13 Q0 99.74
-7.40 Q1 6.26
P30-
RT
2.06 Q0 38.92
0.73 Q0 61.08
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condensation rate even having the highest P content. This suggests that low amounts of 
Ca2+ destabilized the condensed phosphate interactions or increased the phosphate 
condensation temperature above 200 ºC (however, we do not discard a possible oven 
irreproducibility). Regarding the amount of Ca2+, we observed (and it can also be 
observed before thermal treatment but not so precisely) a deshielding of the 31P nuclei 
as the Ca2+ content of the particles increased. Comparison with other CPg in the 
bibliography showed that our particles had a lower phosphate condensation rate. 
Reported CPg are mainly composed by Q2 units [25,32]. However, the amount of Ca2+ 
for these glasses is usually inferior, allowing a higher phosphate condensation. 
Therefore, the phosphate condensation of the current synthesized particles decreased 
due to a higher Ca2+ content. 
 
2.3.5.3. ATR-FTIR spectroscopy 
 
Being consistent with X-ray diffraction analysis (Figure 6A), ATR-FTIR spectroscopy of 
the particles before thermal treatment (Figure 8A) showed the formation of Ca(OH)2 and 
NH4H2PO4 for P0 and P100 particles respectively. The other particles exhibited the 
characteristic sharp bands of well-ordered crystalline CP structures (ν4(OPO) bending, 
ν1(PO) symmetric stretching and ν3(PO) antisymmetric stretching modes) [28–30] plus 
some extra bands. TEP (Figure 9D) and ethanol IR spectra from database [34,35] 
suggest that these extra bands were originated from the vibration of the ethoxide groups 
present in the particles; νs(C-C-O) symmetric stretching, νas(C-C-O) antisymmetric 
stretching, ν(CH) [4] and other unidentified bands. The emission of some of these extra 
bands at similar frequencies than the CP ones made difficult in some cases to 
differentiate them due to overlapping. 
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Figure 8. ATR-FTIR spectra of the particles before A) and after thermal treatment B). 
For exact frequency values and information about band assignment please refer to 
Table 4 and Figure 9. 
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Table 4. ATR-FTIR (Figure 8) band assignment and frequencies (cm-1) of the particles 
before A) and after thermal treatment B). 
 
 
 
 
 
 
 
 
 
 
A) P65-RT P55-RT* P30-RT
ν4(OPO) (Q0)[28-30]
/δ(POP)(Q1)*[4-36]
525, 542;       
569, 583
500, 528
532, 546; 
581
δ(OH-)[29,35] 659
Org. (Figure 9D)
/νs(POP) (Q1)*[4,36]
775; 793 777, 790 772
νs(C-C-O)[34] 840 824 812
Ca(OH)2 (Figure 9B) 865
/ν1(PO)(Q0)[28-30] 908; 959 917; 958 925; 952
ν3(PO)(Q0)[28-30]
/νas(C-C-O)[34]
/νs,as(PO32-)(Q1)*[4,36]
1041, 1078, 
1163
1019, 1057, 
1104, 1187 
1014; 
1047, 
1090; 1137 
EtO- (Figure 9D) 1235 1296 1298
EtO- (Figure 9D)[34]
1371, 1396, 
1447, 1483
1369, 1406, 
1450, 1483
Ca(OH)2 (Figure 9B)
1412, 
1445, 1476
δ(H2O)[28-30] 1633 1662
ν(CH)[4,24,34]
2869, 2909, 
2930, 2975
2877, 2905, 
2933, 2979
2978
Ca(OH)2 (Figure 9B) 3645
B) P65-
200°C
P55-
200°C
P30-
350°C*
δ( -O-P)(Q1*,Q2)[4,36]
 ν4(OPO)(Q0)[28-30]
493 503 563
CaCO3 (Figure 9C) 713
νs(POP) (Q1*,Q2)[4,36] 730 736 743
CaCO3 (Figure 9C) 875
νas(POP)(Q2)[4,36] 910 915
ν1(PO)(Q0)[28-30] 956 957 936
νs(PO32-)(Q1)[4,36]
/ν3(PO43-)(Q0)[28-30]
1085 1115
1034, 
1078
νas(PO32-)(Q1)[4,36]
/ν3(PO43-)(Q0)[28-30]
1120 1115
1078, 
1156
νas(PO2-)(Q2)[4,36] 1215 1203
δ(H2O)[28-30] 1633 1643
CaCO3 (Figure 9C) 1411
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Figure 9. Comparison of the P100-RT A), P0-RT B) and P0-350ºC C) ATR-FTIR 
spectra (Figure 8) with the ©2005-2008, Fiveash Data Management, Inc. (PerkinElmer) 
database. Triethylphosphate FTIR spectrum from online SDBS database [35], showing 
some of the bands assigned to the ethoxide groups (EtO-) (Table 4A) D). 
 
The identification of Q1 units for P55 particles (Figure 7A) means that some of its IR 
bands were originated from the vibration of condensed POP bonds. An interesting 
observation regarding the P30 and P65 particles is the presence of two different double 
ν4(OPO) bands at ~530 and ~580 cm-1. This suggests the presence of two different 
phosphate compounds associated to a possible incorporation of DEP, which could also 
justify some of the observed extra bands.  As we identified in the 31P MAS NMR spectra 
(Figure 7A), P55 particles exhibited broader bands than P65 and P30 particles, indicating 
lower atomic mobility and a more disordered structure [36].  
  ) ) 
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In agreement with X-ray diffraction analysis (Figure 6B), we observed the formation of 
CaCO3 for the thermally treated P0 and P30 particles in the ATR-FTIR spectra (Figure 
8B). After thermal treatment, all particles showed much broader bands, characteristic of 
amorphous CP structures [4,36]. We did not observe the extra bands assigned to the 
ethoxides any more, confirming their decomposition at 200 ºC. The apparition of Q2 units, 
the increase of the Q1 ones and the decrease of the Q0 band intensities indicates a higher 
phosphate condensation for P65 and P55 than for P30 particles. In agreement with the 
31P MAS NMR results (Figure 7B), the ATR-FTIR spectrum of the P65 particles showed 
slightly sharper bands indicating a lower connectivity in the CPg structure. The absence 
of O-H bands at ~3400 cm-1 [4,28,29] before and after thermal treatment indicates the 
almost absence of absorbed moisture and that all free phosphate oxygens were 
interacting with Ca2+.  
 
 
2.3.5.4. 1H NMR characterization of the organic material 
 
To identify the type of organics present in the particles, we dissolved the particles in 
acidic D2O and run a 1H NMR. The spectra of the dissolved particles before thermal 
treatment (Figure 10A), showed the presence of one single ethoxide, being consistent 
with the incorporation of only MEP (Figure 3D). We also detected for P55 and P30 
particles the presence of a minor amount of another ethylphosphate, which we attributed 
to the incorporation of a minor amount of DEP. The presence of DEP, apart from MEP, 
and the incorporation of traces of H3PO4 in the particles (Figure 3B) justify the 
identification of several Q0 units and a double ν4(OPO) vibration band in the 31P MAS 
NMR and ATR-FTIR spectra respectively (Figure 7A, 8A). The almost absence of ethanol 
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in the 1H NMR spectra of the dissolved particles (Figure 10A) indicates a high stability of 
the MEP under acidic conditions [24].  
 
 
 
 
 
 
 
 
 
Figure 10 1H NMR spectra of the dissolved particles before A) and after thermal 
treatment B) in acidic D2O, showing the presence of organics. The acetone identified 
for P0-RT in A) is attributed to impurities from NMR tube cleaning. 
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We also observed a high stability of the DEP and TEP under alkaline conditions in the 
particle synthesis process (Figure 3D). This high pH stability indicates that the 
ethylphosphate condensation is impaired under acidic/alkaline conditions and it only 
occurs at moderately high temperatures (200 ºC). We did not observe the presence of 
other organics in the particles except for P0 that contained traces of MEO-. After thermal 
treatment, the particles were completely inorganic (Figure 10B) except for a tiny amount 
of ethoxide in P65 particles. This tiny amount is consistent with the lower phosphate 
condensation rate observed for P65 than for P55 after thermal treatment (Figure 7B,), 
despite having P65 a higher P content, and suggests that low Ca2+ contents increased 
the needed phosphate condensation temperature above 200 ºC. We also run a 31P NMR 
of the dissolved particles in acidic D2O (Figure 11). Surprisingly, the condensed 
phosphate units of the thermally treated particles were stable at acidic pH and could be 
detected. This finding highlights liquid 31P NMR as an alternative to the more expensive 
and higher sample consuming solid 31P MAS NMR to characterize phosphate glasses. 
We considered the relative abundances of the 31P NMR spectra (Table 5) more precise 
than the 31P MAS NMR ones (Table 3) due to their better spectra resolution. The ratio of 
the different Qn units was similar than in the 31P MAS NMR analysis (Table 3) except for 
P65 that this time did not show a lower phosphate condensation rate than the P55 
particles (Table 5). However, the particles batch used here was different than the one 
used in the 31P MAS NMR. The different batch origin contemplates the possibility that an 
irreproducibility in the oven temperature was the cause of observing a lower phosphate 
condensation rate for P65 in the 31P MAS NMR spectra (Figure 7B). The high amount of 
Q1 units for P65 particles in the 31P NMR spectra (Table 5) suggests the formation of 
trimetaphosphates rather than longer metaphosphates [33,37]. Notice that the Q2/Q1>1/2 
indicates the formation of cyclic trimetaphosphates for P65 particles. 
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Figure 11. 31P NMR spectra of the dissolved thermally treated particles in acidic D2O, 
showing the presence of condensed phosphate units (Qn). Chemical shifts, relative 
abundance and peak assignment in Table 5. 
 
Table 5. Chemical shift, Qn unit, relative abundance and compound assignment of the 
31P NMR spectra (Figure 11) of the thermally treated particles in acidic D2O. Cyclic 
(P3O93-) and open chained (P3O105-) trimetaphosphate, pyrophosphate (P2O74-) and 
amorphous calcium phosphate (ACP). 
 
Chemical shift 
(ppm)
Qn unit
Relative 
abundance (%)
Assignment
P65-200°C (0.51)-(-0.04) Q0 20.12 ACP[31]
(-10.63)-(-11.21) Q1 46.28 (P3O105-/P2O74-)[32,33]
(-21.59)-(-24.42) Q2 33.6 (P3O93-/P3O105-)[32,33]
P55-200°C (0.12)-(-0.05) Q0 13.62 ACP[31]
(-10.6)-(-11.13) Q1 65.53 (P3O105-/P2O74-)[32,33]
(-21.59)-(-22.83) Q2 20.85 (P3O93-/P3O105-)[32,33]
P30-350°C (0.00)-(-0.07) Q0 62.12 ACP[31]
-11.19 Q1 37.89 (P2O74-)[32,33]
 
P65-200°C 
P55-200°C 
P30-350°C 
P0-350°C 
Q
0
 Q
1
 
Q
2
 
20.1% 
13.6% 
62.1% 
46.3% 
65.5% 
37.9% 
33.6% 
20.9% 
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Summarizing the particle characterization section, we achieved before thermal treatment 
the formation of amorphous calcium MEP with the formation of portlandite or NH4H2PO4 
when there was an excess or the absence of Ca2+ respectively. We could not obtain 
particles with P≥65% probably due to the high solubility of the calcium DEP in ethanol. 
The use of more apolar solvents than EtOH in the synthesis process may favor their 
precipitation. After treating the particles at 200 ºC, we observed a decomposition of the 
ethoxide groups and a condensation of the orthophosphate units, being higher the 
condensation as lower was the Ca2+ content. We achieved for P65-200ºC and P55-
200ºC particles, cyclic (Q2) and open chained (Q2/Q1) amorphous calcium 
trimetaphosphate (ACTMP) with traces of amorphous calcium pyrophosphate (ACPP) 
(Q1) and amorphous calcium phosphate (ACP) (Q0) [31–33]. In the bibliography, CPg 
are mainly composed by Q2 units due to their lower Ca2+ content [4,32]. Therefore, P65-
200ºC and P55-200ºC should be considered as low-condensed CPg since they have 
Q1>Q2. As the Ca2+ content of the particles increased, the amount of ACTMP decreased 
until the predominant phase was ACP for P30-350ºC particles. It was necessary a 
thermal treatment at 350 ºC to convert most of the portlandite to calcite. The NH4H2PO4 
decomposed at 200 ºC probably to NH3(g) and H3PO4(l). 
 
 
2.3.6. Bioactive degradation of the CPg nanoparticles 
 
We immersed the particles in buffered HEPES medium at pH 7.4 and 37 ºC to measure 
their ion release in physiological-like conditions. Phosphate buffers were avoided to 
prevent the precipitation of CaHPO4. Apart from measuring the ion release over two 
weeks, we also measured possible pH alterations (Figure 12). Before thermal treatment, 
the particles were very soluble releasing high amounts of Ca2+ during  3 days (Figure 
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12A). The further stabilization of the [Ca2+] and the absence of particles after the 
experiment (Figure 13) confirmed the high solubility of the particles at physiological 
conditions. We attribute this high solubility to the presence of ethoxides, which probably 
disrupted the CP chemical lattice making it less stable and more soluble. The absence 
of inorganic phosphate (Pi) release (Figure 12B) is attributed to the release of MEP 
instead, which was not detected by the malachite green colorimetric method (section 
2.2.11.) [16]. P100 particles released high amounts of Pi because of the dissolution of 
inorganic NH4H2PO4. Although the dissolution of similar CP particles did not show 
cytotoxicity in previous studies [3,10,11], the high stability of MEP under acidic conditions 
(Figure 10A) justifies further studies of how this molecule is metabolized in the body.  
 
 
 
 
 
 
Figure 12. Cumulative Ca2+ A) and Pi B) release and pH changes C) after the 
immersion of the thermally untreated particles, in HEPES media (pH 7.4) at 37 ºC. 
Media was replaced every time point. 
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Figure 13. Microcentrifuge tubes containing the particles after two weeks immersed in 
buffered HEPES media at pH 7.4 and 37 ºC.  
 
There were not significant changes in the pH except for P0 that extremely basified the 
media due to the dissolution of portlandite (Figure 12C). This strong basification may 
limit their use as a biological Ca2+ source. On the other hand, the rest of the particles did 
not alter significantly the pH, making them ideal to release high physiological Ca2+ 
amounts in short periods. Initial Ca2+ concentration increases have demonstrated to favor 
several biological responses for tissue repair such as cell migration, attachment and, 
proliferation, osteogenesis and angiogenesis [2,3,9,10]. If compared with conventional 
CPg or degradable CP ceramics, the Ca2+ release  profile of these organically modified 
particles was faster, suggesting their use to induce earlier biological responses [37–39]. 
P100 particles can be useful to release high amounts of Pi in short periods without pH 
modifications but considering the effects of simultaneously releasing substantial NH4+ 
amounts.  
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Figure 14. Cumulative Ca2+ A) and Pi B) release, and pH changes C) of the immersed 
thermally treated particles in HEPES media (pH 7.4) at 37 ºC. Media was replaced 
every time point. 
 
The thermally treated particles showed a steadier degradability (Figure 14). The Ca2+ 
and Pi release was sustained for two weeks indicating that the decomposition of 
ethoxides and the subsequent increase of CP interactions stabilize the solubility of the 
particles. This time, we detected Pi due to the conversion of the MEP to Pi after thermal 
treatment. The presence of particles after the experiment (Figure 13) confirms their 
higher stability and suggests that further ion release could happen at longer times. 
Correlating the ion release results with the previous particle characterization, we 
identified the CaCO3 followed by the ACP as the phases that released higher amounts 
of Ca2+ (P0-350ºC and P30-350ºC). On the other hand, the ACTMP phase (P55/P65-
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200ºC) released higher amounts of Pi due to their higher P/Ca ration. Although the 
release of pyrophosphate has been reported to participate in bone mineralization [40], 
the stability of higher condensed phosphate units (i.e. trimetaphosphate) under acidic 
conditions (Figure 11) justifies further studies of how this molecule is metabolized by 
cells. The absence of significant pH changes (Figure 14C) validates the use of the 
particles for long-term physiological Ca2+ and Pi release. Although comparison with other 
degradable CP materials is difficult since ion release depends, for instance, on the type 
of used buffer media, its replacement and the material surface area in contact, the 
current particles exhibited similar or moderately higher Ca2+ and Pi releases than more 
complex CPg systems [37–39] and conventional ACP [41,42]. Therefore, their use for 
similar biological applications such as bone regeneration or wound healing is justified 
[3,10,43].  
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2.4. Conclusions 
 
In this study we synthesized for the first time binary (P2O5-CaO) CPg nanoparticles by a 
low-cost and feasible sol-gel synthesis, using ethylphosphate and calcium 2-
methoxiethoxide as precursors. We also gave precise information about the structure 
and solubility of the little-known CPg with CaO>50% [1], before and after thermal 
treatment. We identified by NMR spectroscopy and other complementary techniques the 
formation of highly soluble amorphous calcium MEP (CMEP) for the thermally untreated 
particles, with the presence of portlandite or NH4H2PO4 for an excess or the absence of 
Ca, respectively. After a thermal treatment at 200 or 350 ºC, the CMEP and the 
portlandite of the particles were converted to a more stable, but still degradable, 
inorganic ACTMP, ACPP, ACP and calcite as the Ca content increase respectively. The 
use of a binary CPg system allowed us to control the Ca2+ and Pi release of the particles 
in physiological-like conditions without pH alterations by modifying their P/Ca ratio and 
applying this moderately low thermal treatment. The only presence of biocompatible and 
bioactive ions suggests a safer use compared to other glasses that include body-foreign 
stabilizers such as SiO44-, or Ti4+. The use of the current particles in biological 
applications where high or sustained Ca2+ and Pi concentrations are needed such as 
angiogenesis, osteogenesis or wound healing seems very promising. We would like to 
highlight that the CPg system used in this study is susceptible to allow the incorporation 
of small amounts of other bioactive ions such as Cu2+, Zn2+ or Ag+ to introduce or 
reinforce specific bioactive responses (e.g. angiogenesis, osteogenesis or antimicrobial 
properties). 
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 Chapter 3. Development of Ca2+ 
releasing polylactic acid (PLA) 
nanofiber scaffolds to stimulate 
angiogenesis in bone healing 
applications 
 
 
 
Scheme summarizing the content of the chapter. 
 
 
 
Ca
2+
 
PO
4
3-
 
pH 
hMSCs 
VEGF 
L-lactate 
ALP 
PLA nanofibers containing 
degradable CP nanoparticles 
Scaffold degradation 
HUVEC 
Chick choriallantioic membrane 
(CAM) implantation 
Formation of blood vessels 
Formation of tubes 
 
 
1 mm 
0.5 mm 
84 
 
A proper integration implant-tissue promoted by a correct vascularization is crucial for 
any bone graft. Degradable calcium phosphate (CP) materials have gain interest in bone 
tissue engineering since they stimulate bone formation. However, little is known about 
their angiogenic potential. Recent findings in our group demonstrated that their Ca2+ 
release stimulates the cellular synthesis of vascular growth factors among other 
responses that favor angiogenesis. In this chapter, we combined two of the CPg 
nanoparticles synthesized in Chapter 2 (P55-RT and P30-350ºC), with polylactic acid 
(PLA) nanofibers to achieve scaffolds with fast and sustained Ca2+ release profiles. We 
would like to remember and highlight that these particles were only composed by well-
known biocompatible ions (e.g. Ca2+, PO43-), avoiding the incorporation of body-foreign 
SiO44- and Ti4+. Particles and scaffolds characterization includes; 31P MAS NMR, 1H 
NMR, XRD, EDS, elemental analysis, FE-SEM, tensile-strain assays and DSC. We 
studied the in vitro angiogenic potential of the scaffolds in both regular (RM) and 
osteogenic media (OM). Finally, we evaluated the in vivo formation of new vasculature 
by using the ex-ovo chick choriallantoic membrane (CAM) model. We achieved high 
initial and further sustained Ca2+ and PO43- releases without pH modifications in both RM 
and OM. We observed that the presence of the particles enhanced several angiogenic 
parameters like the VEGF and L-lactate synthesis by hMSCs, the formation of tubes by 
HUVECs and the stimulation of new vasculature in the CAM model. However, some of 
these parameters decreased in OM due to the osteogenic differentiation of hMSCs. This 
study provides an easily tunable Ca2+ releasing platform containing no body-foreign ions, 
with a promising potential not only for bone but also for the regeneration softer tissues in 
which an initial high vasculature is essential.  
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3.1. Introduction 
 
Most of the failures of biomaterials in the field of tissue engineering are in a greater or 
lesser extent due to a bad biointegration with the host tissue. A poor vascularization is 
often the cause since cell death occurs when there is an insufficient blood supply. Bone 
is a highly vascularized tissue and it is specially affected by this problem [1,2]. 
Biodegradable calcium phosphate (CP) materials have been widely used to regenerate 
bone. It is known that their partial dissolution towards the surrounding tissue stimulates 
bone formation [3]. Although, CP materials have also shown to stimulate blood vessel 
formation, which may be one of the reasons of their success as a bone grafts, little is 
known about their angiogenic potential [2]. Recent findings in our group indicates that 
their Ca2+ release has a close correlation with angiogenesis [1,4–6]. Our studies showed 
that these Ca2+-releasing materials promoted the survival and migration of endothelial 
cells as well as the synthesis of angiogenic factors through the stimulation of extracellular 
calcium-sensing receptors (CaSRs) [4]. Moreover, we also observed that degradable CP 
nanoparticles increased the formation of blood vessels in different in vivo models [1,5]. 
This direct cell stimulation minimizes or even eliminates the need of using growth factors 
or exogenous cells with associated risks and elevated money-costs [2]. CP glassy 
systems (more degradable than crystalline CP) often incorporate the presence of extra 
ions (e.g. SiO44-, Ti4+) [7,8] to control their degradability. However, the metabolization and 
side effects of these ions is still unclear [9–11]. In this study, we wanted to avoid such 
ions synthesizing pure CP glasses, whose ion release could be controlled by modifying 
their Ca/P ratio and applying a moderately low thermal treatment (350 ºC). We 
synthesized two different sol-gel CP nanoparticles (containing only Ca and P) with 
different degradability to achieve fast and sustained Ca2+ release rates. We combined 
the particles with electrospun polylactic acid (PLA) nanofibers to obtain implantable 
scaffolds. Characterization of the particles and the scaffolds includes nuclear magnetic 
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resonance (31P MAS NMR, 1H NMR), X-ray diffraction (XRD), energy dispersive X-ray 
spectroscopy (EDS), elemental analysis (EA), field emission scanning electron 
microscopy (FE-SEM), tensile-strain assays and differential scanning calorimetry (DSC).  
We evaluated how the released-by-products (i.e. Ca2+, PO43-, L-lactate and pH) of the 
scaffolds in regular (RM) and osteogenic media (OM) affected in the hMSCs adhesion, 
proliferation, alkaline phosphatase (ALP) activity and VEGF and L-lactate synthesis by 
hMSCs. Finally, we assessed the capacity of the scaffolds to promote angiogenesis 
using the in vitro HUVEC tube formation assay and the ex-ovo chick choriallantoic 
membrane (CAM) model that allows quantify the formation of new blood vessels.   
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3.2. Materials and Methods 
 
If not otherwise specified all reagents were purchased from Sigma-Aldrich. 
 
3.2.1. Sol-gel precursors synthesis 
 
4 M ethylphosphate in ethanol and 1M calcium 2-methoxyethoxide in 2-methoxyethanol 
were synthesized as previously published [1,5]. Briefly, the right amount of phosphorus 
pentoxide (≥99.99%) and metallic calcium granules PS (98%, Panreac) were refluxed in 
distilled absolute ethanol PRS (99,5%, Panreac) or anhydrous 2-methoxyethanol 
(99,8%) respectively under Ar(g) atmosphere for 12 or 24 h respectively. The solutions 
were filtered using 0.45 µm PTFE hydrophobic Minisart® SRP25 syringe filters (Sartorius 
AG, Göttingen, Germany) and stored under Ar(g) at -20ºC. 
 
3.2.2. CP particles synthesis  
 
We synthesized two types of degradable CP nanoparticles with different phosphorus (P) 
contents (P30 and P55). Summarizing, the 4 M ethylphosphate and the 1M calcium 2-
methoxyethoxide precursors were mixed together under vigorous stirring in a ratio of 
1.5:8.5 mL or 4:6 mL in 90 mL of absolute ethanol PRS (99,5%, Panreac) to achieve P30 
or P55 particles respectively. P55 particles were spontaneously obtained after 
approximately 10 minutes of mixing the two precursors. On the other hand, ~30 mL of 
Ammonia PA-ACS (30%, Panreac) were slowly added under stirring to obtain a 
suspension of the P30 particles. Particles were washed/centrifuged at 48384xg for 20 
min twice with absolute ethanol PRS (99,5%, Panreac) and once with hexane ACS 
(≥99%). Afterwards, particles were dried at 70 ºC for 2 h, mild in an agate mortar and 
stored in a desiccator under vacuum. P30 particles were thermally treated at 350 ºC in a 
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muffle furnace L9/11 (Nabertherm, Lilienthal, Germany) for 12 h to eliminate unreacted 
organics and to stabilize their structure. P30-350ºC particles were also stored in a 
desiccator under vacuum.  
 
3.2.3. Scaffolds fabrication  
 
Three different scaffolds; pure polylactic acid nanofibers (PLA), PLA nanofibers 
containing a 60% (w/w) of the P30-350ºC particles (PLA+P30) and PLA nanofibers 
containing a 60% (w/w) of the P30-350ºC particles plus a 20% (w/wPLA+P30) of the P55 
particles (PLA+P30+P55) were fabricated using the electrospinning technique. The used 
electrospinning parameters were adapted from previous studies performed by a former 
PhD student (Dr. Nadège Sachot) [1,5]. Briefly, the right amount of the particles was 
dispersed in 5 mL of 2,2,2-trifluoroethanol (TFE) (99,8%, Panreac), using a Branson 
Digital Sonifier S-450 (Branson Ultrasonics, Danbury, CT, USA). Polylactic acid Purasorb 
PLDL 7038 (Corbion), (70% L-lactate, 30% DL-lactate) inherent viscosity midpoint 3.8 
dL/g, molecular mass 85·104 Da was added to the suspension under vigorous stirring 
until reaching a concentration of 4% (w/wTFE). Once the PLA was dissolved (~4 h), the 
slurries were placed in 5 mL PP/PE syringes and electrospun separately at ~10 KV, ~2 
mL/h and ~12 cm distance tip to collector. Fibers were collected in a cylindrical collector 
covered with parchment paper. The collector spun at 120 rpm to homogenize the scaffold 
thickness through the rotation direction while maintaining a random fiber distribution. 
 
 
3.2.4. Particles and scaffolds characterization 
  
3.2.4.1. Energy dispersive X-ray spectroscopy (EDS) of the particles was performed 
in a Quanta Q200 scanning electron microscope (SEM) (FEI Company, Hillsboro, OR, 
USA) coupled with an EDS detector to determine their P and Ca content. Particles were 
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analyzed at 20 KV, 10 mm working distance and were previously coated with a thin 
carbon layer to improve conductivity. Values express the average of at least three 
different measurements. 
 
3.2.4.2. Elemental analysis (EA) of the particles was performed by combustion in an 
elemental analyzer EA CE 1108 (Thermo Fischer Scientific, Waltham, MA, USA) to 
determine their C and N content. Approximately, 2000 µg of the particles were weighed 
in a MX5 microbalance (Mettler-Toledo, Greifensee, Switzerland). The samples were 
analyzed by combustion at 1060 ºC using atropine as standard. A mixture of vanadium 
pentoxide and lead powder was added to facilitate combustion. 
 
3.2.4.3. X-ray diffraction (XRD) was performed in a PANalytical X’Pert PRO MPD 
Alpha1 Powder diffractometer (PANalytical, Almelo, the Netherlands) to determine the 
crystalline phases in the particles. Approximately, 100 mg of the particles were pressed 
in a cylindrical standard sample holder of 16 mm of diameter and 2.5 mm of height. 
Samples were analysed in a Bragg-Brentano /2  240 mm radius geometry. We 
interpreted the spectra with the ©PANalytical X’Pert HighScore software (PANalytical, 
Almelo, the Netherlands) and the database PDF2 (2001) from the international center of 
diffraction data (ICDD). 
 
3.2.4.4. 31P MAS NMR spectroscopy of the particles was performed in a 400 MHz-WB 
Avance-II spectrometer (Bruker, Billerica, MA, USA) externally referenced to 
H3PO4 (85%) to determine the presence of condensed phosphate units. Approximately, 
50 mg of the particles were placed in a ZrO2 4 mm rotor and spun at 12 kHz. HPDEC.AV 
standard pulse sequence was used to run the experiments with a 5 µs pulse length 
corresponding to a 90º tip angle. The recovery delay was set to 5 s. A total of 512 scans 
were accumulated for each spectrum to have a good signal-to-noise ratio. 1H nuclei was 
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decoupled using Spinal-64 scheme (at 73 watts power level). Data was processed 
applying a FT exponential function (line broadening, lb 15 Hz).  
 
3.2.4.5. 1H NMR spectroscopy of the dissolved particles in acidic heavy water (D2O) 
was performed in a Bruker 400 MHz Avance III spectrometer (Bruker, Billerica, MA, USA) 
equiped with a Prodigy TCl 5 mm cryoprobe to characterize the presence of 
organics. Approximately, 5 mg of the particles were dissolved separately in 1 mL of D2O 
(99.9%) containing 1.5% (v/v) of HCl (37%, Panreac). Spectra were registered between 
16 and -3.8 ppm, applying 3.66 µs, 30° pulse, a delay of 1 s between pulses, and an 
acquisition time of 2.5 s. 32 scans were collected to have a good signal-to-noise ratio. 
Data was analyzed using the ACD/Spectrus Processor software [12]. 
 
3.2.4.6. Field emission scanning electron microscopy (FE-SEM) images of the fibers 
were performed in a NOVA NanoSEM-230 ultrahigh-resolution field emission scanning 
electron microscope (FE-SEM) (FEI Company, Hillsboro, OR, USA) to determine the 
morphology of the scaffolds. Scaffolds were previously coated with a thin carbon layer 
to improve conductivity. Samples were irradiated at 5 KV at a working distance of 5 mm. 
 
3.2.4.7. Mechanical properties of the scaffolds were characterized by applying 
tensile-strain tests at room temperature using a Zwick-Roell Z0.5TN testing machine 
(Zwick Roell Group, Ulm, Germany). Four samples per each scaffold were cut into ISO 
257-1/2 standardized test specimens of 50x5 mm using a stainless-steel punch and a 
surgical blade. The tensile-strain was calculated on the nominal cross-section area of 
the specimens. We used a caliper and a digital micrometer to measure the exact width 
and thickness of the samples. The average thickness ranged from 50 to 150 µm. The 
Young’s modulus was considered as the slope of the linear region of the tensile-strain 
curve. The ultimate strength was considered as the maximum tensile stress supported 
by the material. The strain to failure was fixed to the previous point before a 40% of loss 
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of the tensile strength. The tensile-strain test was monitored at a speed of 10 mm·min-1 
using a force cell of 10 N. We used the testXpert II testing software (Zwick Roell Group, 
Ulm, Germany) to process the data.  
 
3.2.4.8. Differential scanning calorimetry (DSC) was performed in a DSC Q20 (TA 
instruments, New Castle, DE, USA) coupled with a nitrogen chiller to determine the 
thermal properties of the PLA in the scaffolds. Random ~9.4 mg pieces of each scaffold 
were placed in aluminum hermetic pans and submitted to two heating cycles from -90 to 
200 ºC at 10 ºC·min-1, with a nitrogen cooling between cycles. We determined the 
crystallization and melting properties of the PLA from the curve of the first cycle. From 
the curve of the second cycle we assessed the glass transition temperature (Tg) applying 
the inflexion point method. We used the Universal Analysis software v4.7A (TA 
instruments, New Castle, DE, USA) to process de data. 
  
3.2.5. In vitro experiments 
 
If not otherwise specified all percentages refer to volume. 
 
3.2.5.1. Cell expansion  
 
Adult human mesenchymal stem cells (hMSCs) from bone marrow passage 2 provided 
by the Texas A&M Health Science Center College of Medicine Institute for Regenerative 
Medicine at Scott & White through a grant from NCRR of the NIH, Grant # 
P40RR017447, were expanded in 175 cm2 EasyFlask™ Nunclon™ (Thermo Fischer 
Scientific) with minimum essential medium (αMEM) w/o nucleosides (1X) (Gibco®) 
complemented with 16.5% of characterized fetal bovine serum (FBS) HyClone™ (GE 
Healthcare), 1% of L-glutamine (200 mM, Invitrogen™) and 1% of penicillin-streptomycin 
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(104 U/mL, Invitrogen ™). Human umbilical vein endothelial cells (HUVECs) 
(EndoGRO™) passage 2 were expanded in 175 cm2 EasyFlask™ Nunclon™ (Thermo 
Fischer Scientific) with EndoGRO-LS complete culture media (Merck Millipore) plus 1% 
of penicillin-streptomycin (104 U/mL, Invitrogen™). Both cell types were incubated under 
sterile conditions at 37 ºC, 5% CO2 and a high moisture level. Medium was replaced 
every 2-3 days. Before reaching confluence (~5 days) cells were extracted using 
TrypLE™ Express Enzyme (1x) phenol red (Gibco®) and used for the in vitro 
experiments.  
 
3.2.5.2. hMSCs seeding on the scaffolds  
 
Discs of 6 mm of the different scaffolds (PLA, PLA+P30 and PLA+P30+P55) were cut 
using a Harris Uni-Core™ 6.0 mm punch (Whatman plc, Little Chalfont, UK) and 
sterilized under UV-light. The discs were placed in ultra-low attachment 96-well plates 
Nunclon™ Sphera™ (Thermo Fischer Scientific). We prepared four replicates per 
condition. Before seeding the cells, discs were wet using a sterile-filtered 30% absolute 
ethanol PRS (99,5%, Panreac) solution in milli-Q water. The ethanol solution was 
removed, and the scaffolds discs were cleaned twice with complete αMEM. The discs 
were left without media but wet in the incubator overnight. 104 hMSCs/scaffold were 
seeded in 80 µL of complete αMEM or osteogenic media (complete αMEM supplemented 
with 100 nM of dexamethasone (≥97%), 50 µM of L-ascorbic acid 2-phosphate trisodium 
salt (≥95.0%) and 10 mM of β-glycerophosphate disodium salt hydrate (≥99.0%)). A 
control of hMSCs (TCP) on 96-well plates Nunclon™ Delta (Thermo Fischer Scientific) 
was performed to confirm a normal cell behavior. Media was replaced every 2-3 days.  
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3.2.5.3. Ca2+, PO43-, pH, L-lactate, VEGF, total DNA and ALP activity quantification 
 
After 1, 3, 6, 13 and 20 days the media from section 3.2.5.2. were extracted and frozen 
at -80 ºC for later Ca2+, PO43-, pH, L-lactate and VEGF quantification. At the same time 
points, hMSCs were lysate to measure total DNA and ALP activity. To lysate the hMSCs 
we followed the instructions provided in the SensoLyte® pNPP Alkaline Phosphatase 
Assay Kit (AnaSpec Inc.). Briefly, the discs were placed in 1.5 mL centrifuged microtubes 
with 125 µL of the 10x buffer plus 1x Triton-X (both included in the kit). The tubes were 
placed on ice to preserve the DNA. The discs were smashed, cut (using a surgical 
scissors) and sonicated for 10 s with an Ultrasonic Processor UP50H (Hielscher 
Ultrasonics, Teltow, Germany) to ensure a correct extraction of the DNA and ALP. The 
hMSCs from the TCP (with 125 µL of the lysate solution) were scratched from the bottom 
of the wells using PP ultra-micro pipet tips (VWR international), sonicated as before 
mentioned and the media were transferred into microtubes. All microtubes were 
centrifuged at 104xg for 15 min and 110 µL of the supernatant were frozen at -80 ºC for 
further DNA and ALP quantification. To measure the DNA we used the Quant-iT™ 
PicoGreen™ dsDNA Assay kit (invitrogen™). The calibration curve was prepared using 
the same buffer media (10x buffer + 1x Trito-X) that we used to lysate the cells since 
Triton-X increases PicoGreen™ fluorescence intensity. To measure the ALP activity, we 
used the SensoLyte® pNPP Alkaline Phosphatase (ALP) Assay Kit (AnaSpec Inc.). The 
VEGF, L-lactate and PO43- from the extracted media were measured using the Human 
VEGF DuoSet® ELISA Kit (R&D Systems™), the D/L-Lactate UV method kit (Nzytech) 
and the Phosphate Colorimetric Assay Kit respectively. To measure the Ca2+ content we 
used an adapted colorimetric method based on the O-Cresolphthalein complexone 
[13,14], which absorbance intensity was measured at 570 nm (see Chapter 2, section 
2.2.11.). Finally, we measured the pH with a Crison 50 28 pH electrode connected to a 
Crison pH-Meter GLP 22+ (Hach Company, Loveland, CO, USA). Samples were diluted 
if necessary. All absorbance and fluorescence intensities were measured in an Infinite 
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M200 Pro Microplate Reader (Tecan Group Ltd., Männedorf, Zürich, Switzerland). Since 
ALP, VEGF and L-Lactate were cell dependent we normalized them by the total hMSCs 
DNA. 
 
 
 
3.2.5.4. HUVECs tube formation assay 
 
104 hMSCs were seeded on the 6 mm scaffolds discs and on the TCP (20 replicates per 
condition) as previously explained in section 3.2.5.2.. At day 3, 13 and 20, the media 
from the replicates of each condition were pooled and frozen at 80 ºC for later use. 50 
µL of Matrigel® Growth Factor Reduced (Corning Inc.) were placed at 8 ºC on 96-well 
plates Nunclon™ Delta (Thermo Fischer Scientific) and incubated at 37 ºC for 30 min to 
allow gelation. When the Matrigel® was set, we seeded 1.5·104 HUVECs/well in 80 µL 
of αMEM, four replicates per condition. Cells were incubated for 1 h to allow their 
attachment, afterwards the media were removed and replaced with 80 µL of the extracted 
regular media (ERM). The ERM were previously warmed at 37 ºC and centrifuged to 
eliminate artifacts that could affect image analysis. After 8 h of incubation, we 
photographed the HUVECs using an inverted DM IL LED microscope (Leica 
Microsystem, Wetzlar, Germany). Images were analyzed using the Angiogenesis 
Analyzer ImageJ plugin [15] to evaluate the tube network produced. A negative control 
(NC) with complete αMEM (RM) was performed to compare samples with a non-
promoting angiogenic condition. We used the average of the statistical differences (Pvalue) 
with the NC of all the measurements performed by the Angiogenesis Analyzer plugin 
(Figure 12) to evaluate the quality of the tube network produced. 
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3.2.6. Ex-ovo chick choriallantoic membrane (CAM) model 
 
This protocol was adapted from [16]. Briefly, fertilized chick eggs (Granja Gibert S.A., 
Cambrils, Spain) were incubated at 37.5 ºC in an SI 24 eggs incubator (Lincu Avitec S.L., 
Valencia, Spain) with air ventilation and a high humid atmosphere. After 3 days, the eggs 
were cracked, and the full embryos were placed in Falcon™ standard tissue culture 
dishes 100x20 mm (Corning Inc.) surrounded with sterile phosphate buffered saline 
(Gibco®) solution to maintain a high moisture level. After 6 more days of incubation, 
scaffolds discs (only PLA and PLA+P30+P55) of 6 mm were placed on the CAM near to 
the big blood vessels (Figure 1). We implanted 30 replicates per condition distributed in 
7 different embryos. The discs were previously set on UV-sterilized 6 mm nylon net filters 
discs (Merck Millipore Ltd.) and fixed with 30 µL of 2 mg/mL Opticol™ Rat Type I 
Collagen (3.8 mg/mL, Cell Guidance Systems) solution to avoid scaffold shrinkage 
during implantation. Briefly, the Opticol™ (3.8 mg/mL, Cell Guidance Systems) was 
mixed with the included neutralizing solution at a ratio of 9:1 (v:v), the mixture was diluted 
to 2 mg/mL with complete αMEM. 30 µL of this solution were placed on each mounted 
scaffold on the nylon discs and previously wet as mentioned in the hMSCs seeding 
section 3.2.5.2.. The Opticol™ was allowed to jellify at 37 ºC for 45 min. A positive control 
of PLA plus 200 ng of Recombinant Human VEGF 121 (PeproTech®) was implanted to 
compare samples with a known angiogenic condition. We also implanted the scaffolds 
with hMSCs after 13 days of culture (PLA+hMSCs and PLA+P30+P55+hMSCs), in which 
the neutralized Opticol™ solution (2mg/mL) was prepared with the hMSCs ERM at day 
13. After 3 days of implantation, the embryos were sacrificed by decapitation and the 
discs and the surrounding CAM were fixed with Formalin solution neutral buffered (10%). 
After 25 min, the fixed discs were cut and photographed from the side in contact with the 
CAM in a MVX10 Macro Zoom Microscope (Olympus Corporation, Tokyo, Japan). The 
small blood vessels on each scaffold were quantified by using an own-developed ImageJ 
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macro (Figure 14), which briefly, quantifies the pixels occupied by the small blood 
vessels and normalizes it by the total area analyzed in pixels.  
 
 
Figure 1. Picture showing the implantation of the scaffolds in the ex-ovo CAM model. 
 
 
3.2.7. Statistical analysis 
 
Statistics were performed using GraphPad Prism 6. A two-way ANOVA and a Tukey’s 
multiple comparison test was used in the in vitro experiments to observe both; statistical 
differences between conditions at each time point, and statistical differences of each 
condition between consecutive time points. For the tube formation assay (section 
3.2.5.4.), we used a Dunnet’s multiple comparison test to detect statistical differences 
with the NC (Figure 12). It was considered that all values in the in vitro experiments 
followed a Gaussian distribution, although not enough replicates (n=4) were taken to 
perform a D’Agostino-Pearson omnibus normality test. We analyzed statistical 
differences between conditions in the CAM model (section 3.2.6.) using a one-way 
ANOVA and a Tukey’s multiple comparison test. The D’Agostino-Pearson omnibus 
normality test confirmed that all values in section 3.2.6. followed a Gaussian distribution.  
We used the one-tailed t test to confirm the previous hypothesis of observing a statistical 
higher amount of new blood vessels in the PLA+P30+P55 scaffolds than in the pure PLA 
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ones [17]. The F test (in the t-test) confirmed no statistical differences between 
variances. All conditions in all sections were considered unmatched. We considered only 
Pvalues<0.001 (*) and <0.0001 (**) in section 3.2.5.3. due to the found high amount of 
statistical differences. We considered Pvalue<0.05 (*), <0.01 (**), <0.001 (***) and <0.0001 
(****) for the other sections. Columns in the graphs represent means and error bars the 
standard error of the mean (SEM). 
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3.3. Results & discussion 
 
3.3.1. CP particles and scaffolds characterization 
 
As we previously discussed in Chapter 2, we identified the P30-350ºC particles as a 
mixture of amorphous calcium (pyro)phosphate (ACP and ACPP) and CaCO3, while the 
P55-RT particles were mainly an amorphous calcium monoethylphosphate salt. 31P MAS 
NMR spectra (Figure 2A) showed the presence of orthophosphate units (Q0) and a small 
amount of pyrophosphates (Q1) in both particles [18,19]. X-ray diffraction spectrum 
(Figure 2B) revealed also the formation of calcite (CaCO3) for P30-350ºC. 
 
 
Figure 2. 31P MAS NMR A) and X-ray diffraction B) spectra of the P30-350ºC and P55-
RT particles. 
 
Table 1. Particles P/Ca atomic ratio (%) measured by EDS and C and N mass % 
measured by EA. 
 P /Ca ratio               
(atomic %) 
C         
(mass %) 
N          
(mass %) 
P55-RT 54.2/45.8 17.78 ≤ 0.2 
P30-350ºC 29.8/70.2 5.66 ≤ 0.2 
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The detection of only P and Ca by EDS (Table 1) indicates that the phosphates were in 
form of calcium phosphates (CP). The inexistence of crystalline CP phases (Figure 2B) 
shows that P30-350ºC and P55-RT particles contained amorphous CP. However, we did 
not consider them as glasses due to their low rate of phosphate condensation (amount 
of Q2 and Q1 units) (Figure 2A) [19–21]. We attribute the carbon (C) detected for P30-
350ºC particles (Table 1) to the formation of CaCO3 while the one for P55-RT to the 
presence of organics.  
 
Figure 3. 1H NMR spectra of the dissolved P55-RT and P30-350ºC particles in acidic 
D2O. Peak assignment is based on the information obtained in Chapter 2, section 
2.3.5.4.. 
 
The 1H-NMR spectra of the dissolved P55-RT particles in acidic D2O (Figure 3) showed 
that these organics were monoethylphosphate (MEP) and a small amount of 
diethylphosphate (DEP). On the other hand, the absence of organics for the dissolved 
P30-350ºC particles confirms that the detected C in Table 1 came from the CaCO3. With 
this information we conclude that the P30-350ºC particles were a mixture of amorphous 
CP (ACP) [18], amorphous calcium pyrophosphate (ACPP) [19,22] and calcite (CaCO3). 
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On the other hand, we considered P55-RT particles as an amorphous calcium MEP salt. 
We attributed the higher phosphate condensation of P30-350ºC (despite having less P 
content than P55-RT) to the thermal treatment applied, while the formation of CaCO3 
was attributed to the carbonatation of the excess Ca at 350 ºC. Notice that the presence 
of ethoxides for P55-RT was due to these particles were not thermally treated.  
 
 
Figure 4. Morphological FE-SEM images of the different PLA nanofiber scaffolds. 
PLA+P30 scaffolds contained a 60% of the P30-350ºC particles. The PLA+P30+P55 
scaffolds contained the same amount of P30-350ºC plus a 20% of the P55-RT 
particles. 
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From now on, we will refer to P55-RT and P30-350ºC particles as P55 and P30. FE-SEM 
images of the electrospun scaffolds (Figure 4) showed significant smaller fibers 
diameters for the scaffolds containing the particles (~1 vs ~2 µm). It may be that the 
partial degradation of the particles during the dissolution of the PLA before 
electrospinning modified the pH or partially degraded the PLA molecules reducing the 
solution viscosity. Changes in the polymer solution viscosity or conductivity are known 
to have an effect in the diameter size of the electrospun fibers [23]. Although the fibers 
contained some particles aggregates of several µm (Figure 4), they were well packaged 
inside the fibers suggesting no particle detachment after implantation. This good 
packaging suggests an attractive electrostatic interaction between the PLA and the 
particles, which is important to integrate the mechanical properties of the particles into 
the scaffold. This attractive interaction may have affected in the fiber diameter reduction. 
On the other hand, we observed a random fiber distribution for all scaffolds. 
Tensile-strain tests (Figure 5A, Table 2) showed that the scaffolds containing the 
particles (PLA+P30 and PLA+P30+P55) were mechanically weaker than the pure PLA 
ones. We attributed this significant decrease to the high amount (≥60%) of particles in 
the fibers, which most likely reduced and disrupted the continuity of the polymer matrix 
reducing its capacity to withstand a given stress. We also attribute a contribution in the 
decrease of the mechanical properties to a PLA fiber diameter reduction, observed in 
the FE-SEM images (Figure 4). Mechanically speaking, such load of particles does not 
seem a proper choice to support the stress that bone is submitted. However, we must 
consider that in tissue regeneration the aim is to stimulate the own body to restore the 
tissue mechanics and functions rather than to create an ideal substitute, as long as the 
scaffold withstands the stress of implantation and the hydrostatic pressure of the body 
[24]. Looking at the osteoid (the unmineralized organic matrix prior to the maturation of 
bone tissue) our scaffolds had similar mechanical properties [25]. In this thesis, we were 
focused on increasing the bioactive potential of the scaffolds to accelerate the bone 
healing process. Since the mechanical properties of the scaffolds allowed their proper 
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manipulation in the biological experiments (see next sections), we decided to maintain 
such load of particles and therefore increase the ion release and bioactivity of the 
scaffolds.  
 
 
Figure 5. Tensile-strain tests A) and differential scanning calorimetry (DSC) 
measurements B) of the different scaffolds. 
 
 Table 2. Young’s modulus (E), ultimate strength (σMax), strain to failure (ɛMax) and PLA 
glass transition temperature (Tg) of the different scaffolds. 
 
 
 
 
On the other hand, the DSC results (Figure 5B, Table 2) showed a similar PLA glass 
transition temperature (Tg) for all the scaffolds. The absence of crystallization 
temperature indicates that the PLA in all the scaffolds was amorphous. Both results show 
up that the partial dissolution of the particles during the electrospinning technique did not 
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alter the PLA molecular length. Therefore, the observed changes in the mechanical 
properties (Figure 5B, Table 2) and fiber diameter (Figure 4) were induced more likely 
by the high amount of the particles in the scaffolds. We observed a significant amount of 
water for the scaffolds containing the particles (Figure 5B), even though we lyophilized 
the samples before analysis. This indicates a high affinity of the particles to absorb water, 
especially for P55 particles. We also observed the calorimetric loss of the decomposition 
of ethoxides and phosphate condensation of the MEP present in the P55 particles at 
~160 ºC, indicating that the condensation process started at lower temperatures than the 
200 ºC used in Chapter 2 section 2.2.2..    
 
 
3.3.2. Ion release and pH modifications of the scaffolds in regular (RM) and 
osteogenic (OM) media after seeding hMSCs. 
 
The release of bioactive ions (e.g. Ca2+, PO43-) and pH changes play an important role 
in the biological behavior of cells. We measured the ion release and pH modification of 
the different PLA nanofiber scaffolds in regular (RM) and osteogenic media (OM) after 
seeding hMSCs (Figure 6). Notice that we expressed the real ion concentration in the 
medium, not the cumulative one, since we considered this to have an effect in the hMSCs 
behavior. For cumulative ion release please refer to Figure 7. We chose the P55-RT 
particles to release high initial Ca2+ amounts due to their high solubility without pH 
alterations (Chapter 2, Figure 12). On the other hand, we used the P30-350ºC particles 
to release sustained Ca2+ amounts. We chose P30-350ºC particles over P0-350ºC 
particles, even having P30-350ºC a lower Ca2+ release profile (Chapter 2, Figure 14A) 
because P0-350ºC were insoluble in cell culture conditions (Figure 8).  
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Figure 6. [Ca2+], [PO43-] and pH modifications of the different PLA nanofiber scaffolds 
after seeding hMSCs in RM and OM (n=4). Media was replaced every time point. We 
only considered Pvalue<0.001 (*) or <0.0001 (**) due to the high number of statistical 
differences.  
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Figure 7. Cumulative Ca2+ and PO43- release from Figure 6. Notice that the high 
increase in the PO43- release in the OM is attributed to an increase in the ALP activity 
of the hMSCs. 
 
We hypothesized that the presence of HCO3-(aq) in the cell medium, and the CO2(g) 
atmospheric saturation of the incubator avoided the dissolution of the CaCO3 present in 
the P0-350ºC particles [26]. Moreover, P30-350ºC particles also released PO43-, which 
we considered positive due to its participation in bone mineralization. Returning to the 
scaffolds ion release results, we observed that the PLA+P30+P55 scaffolds released 
high initial amounts of Ca2+ during the 3 first days (Figure 6A), confirming the high 
solubility of the P55 particles. Then both scaffolds (PLA+P30 and PLA+P30+P55) 
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released about the same amount of Ca2+ and PO43- (Figure 6A, 6C) due to the presence 
of the more stable P30 particles. The lack of PO43- burst at day 1 and 3 for the 
PLA+P30+P55 scaffolds was attributed to the release of MEP by the dissolution of the 
P55 particles (Figure 3).  
 
 
Figure 8. Cumulative Ca2+ release of PLA nanofiber scaffolds containing a 20% of P0-
350ºC particles, immersed in 0.05 M HEPES buffered media (pH 7.4) plus ~1.4 mM 
CaCl2 at 37 ºC. Fibers were incubated separately in normal (PLA+P0-350ºC) and 5% 
CO2(g) incubators (PLA+P0-350ºC (CO2)). We observed the absence of Ca2+ release in 
the presence of 5% CO2(g), suggesting that its absorption in the medium avoided the 
dissolution of the P0-350ºC particles. 
 
The pure PLA fibers showed similar Ca2+ and PO43- values than the tissue culture plate 
(TCP), indicating no Ca2+ or PO43- absorption by the PLA fibers. Notice that the media 
initially contained about 1.8 mM of Ca2+ and 1.6 mM of PO43-. The higher PO43- 
concentration for the PLA scaffolds and the TCP at day 1 in the OM (Figure 6C, 6D), is 
attributed to the presence of β-glycerophosphate. The Ca2+ and PO43- release by the 
scaffolds in the OM was similar than in the RM during the 6 first days (Figure 6B, 6D), 
demonstrating that the scaffolds could maintain such ion concentration in an osteogenic 
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environment. Then we observed a significant decrease of the Ca2+ concentration in the 
OM that suggests a Ca2+ precipitation. This precipitation matches with an increase in the 
PO43- concentrations from day 13 (Figure 6D) that we correlate with an increase in the 
ALP activity of the hMSCs. The Ca2+ concentration values in both RM and OM were in 
the described range to stimulate the extracellular calcium-sensing receptor (CaSR) 
involved in cell chemotactic responses such as cell migration, proliferation or 
angiogenesis [4,5]. We did not observe changes in the pH for any condition, validating 
their use for biomedical applications (Figure 6E, 6F). Notice that the pH values were 
slightly basic because they were measured outside the incubator where the lower PCO2(g) 
affected in the CO2(g)/HCO3-(aq) buffer equilibrium of the medium.  
 
 
3.3.3. hMSCs adhesion and proliferation 
 
hMSCs are present in many tissues and have the ability to differentiate into different cell 
types. One of these differentiated hMSCs are osteoblast, the cells in charge of 
extracellular matrix production in bone remodeling and bone healing. For this reason, 
hMSCs are object of study for bone regenerative applications. Moreover, hMSCs 
participate in the formation of blood vessels releasing several angiogenic factors that 
guide endothelial cells to produce blood vessels. We measured the hMSCs adhesion 
and proliferation from section 3.3.2.. We observed that the presence of the particles 
enhanced the hMSCs adhesion in both RM and OM (Figure 9A, 9B). Notice that the 
lower cell adhesion in the OM is attributed to a cell loss during the seeding process. The 
lack of relevant differences between the PLA+P30 and the PLA+P30+P55 scaffolds 
suggests that the P55 particles and hence higher initial Ca2+ concentrations (Figure 6A, 
6B) did not increase cell adhesion. The hMSCs proliferation results showed a low 
increase in RM (Figure 9C), which was unexpected due to the high proliferative capacity 
of MSCs. However, the absence of significant differences with the TCP discards the 
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scaffolds as the responsible. Some in vitro studies have shown low hMSCs proliferative 
rates indicating that hMSCs not always have a strong proliferative behavior [27–29].  
 
Figure 9. hMSCs adhesion A), B) and proliferation C), D) on the PLA nanofiber 
scaffolds in RM and OM (n=4). Pvalue<0.001 (*), <0.0001 (**). Stars (*) on columns refer 
to differences with the TCP. 
 
In contrast, we observed a significant higher proliferation when the hMSCs were cultured 
in the OM (Figure 9D), which was neither expected since the differentiation of hMSCs 
should decrease cell proliferation. However, we must consider that the osteogenic 
differentiation of hMSCs is a long process that takes several steps and some of them 
may allow cell proliferation. Moreover, in accordance to some studies, the 
dexamethasone present in the OM induces hMSCs proliferation [30–35]. We observed 
a significant higher hMSCs proliferation on the fibers containing the particles than on the 
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pure PLA ones and the TCP at day 20 in OM (Figure 9D), indicating that the presence 
of the particles increased the hMSCs proliferation in OM. The lower proliferation 
observed at the same day for the PLA+P30+P55 scaffolds compared to the PLA+P30 
suggests that the initial increase in Ca2+ concentration (Figure 6B) did not increase the 
hMSCs proliferation. 
 
 
3.3.4. Increase in the ALP activity 
 
Alkaline phosphatase (ALP) is an enzyme early expressed in the osteogenic 
differentiation of hMSCs. It participates in bone mineralization, increasing the local 
concentration of PO43-. Its early expression is the reason of being one of the most 
measured markers to identify the osteogenic differentiation of hMSCs. We measured the 
ALP activity of the hMSCs from the previous sections. As expected, we only observed 
an increase in the ALP activity in the OM (Figure 10B), suggesting that the scaffolds 
were not osteoinductive but supported the differentiation of hMSCs in an osteogenic 
environment. However, the ALP activity did not increase until day 13, being in 
accordance with the increase in the PO43- concentration (Figure 6D). Although, it is 
standardized that the ALP activity normally rises at earlier stages, some studies also 
reported late increases [33,34,36,37]. It is difficult to stablish a standard pattern for the 
ALP activity or other metabolic activities (e.g. cell proliferation) since hMSCs biology can 
present big differences depending, for instance, on donor metabolism, heterogeneity of 
the extracted cell population or type of serum used [38–40]. We observed that the 
PLA+P30 scaffolds supported the highest increase in the ALP activity at day 20 in OM 
(Figure 10B) suggesting that the P30 particles induced a stronger differentiation. Again, 
we failed to observe that the initial increase of [Ca2+] induced by the PLA-P30-P55 
scaffolds (Figure 6A) had a positive effect in the increase of ALP activity. 
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Figure 10. Increase of ALP activity by the hMSCs seeded in the different PLA 
nanofiber scaffolds in RM A) and OM B) (n=4). Pvalue<0.001 (*), <0.0001 (**). 
 
 
3.3.5. L-lactate production 
 
We measured the L-lactate released by the PLA nanofibers (Figure 11) since L-lactate 
have been reported to be angiogenic [41–44]. However, the L-lactate concentration in 
the media was overly too high to only stem from the dissolution of the PLA nanofibers. 
We assigned these high values to the production of L-lactate by the own hMSCs. It has 
been reported that hMSCs undergo anaerobic glycolysis increasing the [L-lactate] even 
in normoxia conditions due to their adaptation to hypoxia stresses in vivo [45–47]. We 
normalized the L-lactate concentration by the total DNA since it was cell dependent. 
Notice that we considered insignificant the L-lactate released by the fibers. We observed 
that the L-lactate production in RM (Figure 10A) was statistically higher in all the scaffolds 
than in the TCP, indicating a higher metabolic activity due to a scaffold-hMSCs 
interaction. After 6 days, we detected a lower L-lactate production for the pure PLA 
scaffolds without particles, indicating that the P30 particles prolonged this higher hMSCs 
metabolic activity.  
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Figure 11. L-lactate production by the hMSCs seeded on the different PLA nanofiber 
scaffolds in RM A) and OM B) (n=4). Pvalue<0.001 (*), <0.0001 (**). 
 
L-lactate has been identified as an angiogenic promoter for both wound healing and brain 
[41–44]. Hence releasing high amounts of L-lactate may stimulate the formation of initial 
vasculature. The decrease in L-lactate production in OM (Figure 11B) indicates that even 
though we did not observe an increase in the ALP activity until day 13 (Figure 10B), from 
day 3 the metabolic activity of the hMSCs was completely different, suggesting cell 
differentiation at earlier stages. Indeed, it has been reported a decrease in the anaerobic 
glycolysis for the osteogenic differentiation of hMSCs, which results in a decrease of the 
L-lactate production [45,46]. The decrease of L-lactate concentration for all conditions 
from day 13 in both media matches with an increase in cell proliferation (Figure 9C, 9D) 
and ALP activity (Figure 10B), suggesting a close correlation. 
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 3.3.6. VEGF synthesis 
 
Vascular endothelial growth factor (VEGF) is one of the most well-known angiogenic 
factors that regulates the formation, maintenance and sprouting of blood vessels [48]. 
hMSCs are known to participate in the stimulation of new vasculature by synthesizing 
different growth factors, among them the VEGF [6,49,50]. Therefore, we measured the 
synthesized VEGF by the seeded hMSCs as an in vitro marker of the angiogenic 
potential of the scaffolds (Figure 12).  
  
 
Figure 12. VEGF synthesis by the hMSCs seeded on the different PLA nanofiber 
scaffolds in RM A) and OM B) (n=4). Pvalue<0.001 (*), <0.0001 (**). 
 
We observed that the VEGF synthesis followed an almost identical tendency than the L-
lactate production (Figure 11). It has been stated for wound healing that the release of 
high amounts of L-lactate may induce to the hMSCs the biological perception of a 
hypoxia state even in normoxia conditions [42]. This can activate several angiogenic 
mechanisms among them the synthesis of VEGF [42]. The high VEGF synthesis in RM 
by all the scaffolds in comparison to the TCP until day 6 (Figure 12A) suggests a high 
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angiogenic potential. However, only the particle-containing scaffolds prolonged higher 
[VEGF] until day 20. We could not correlate an increase in the VEGF synthesis with a 
[Ca2+] increase (Figure 6A, 6B). Nevertheless, the angiogenic effects of the released L-
lactate [41–44] may have masked those from the Ca2+ [4]. The low synthesis of VEGF in 
the OM (Figure 12B) suggests a lower angiogenic stimulation due to the osteogenic 
differentiation of the hMSCs. However, we must consider that the formation of blood 
vessels is a complex process that involves other parameters apart from hMSCS and the 
synthesis of VEGF. 
 
 
3.3.7. HUVECs tube formation assay 
 
In angiogenesis, endothelial progenitor cells are assembled together producing a tube-
like network structure that later will mature into micro blood vessels [51]. This network 
producing capacity is evaluated in vitro to test the angiogenic potential or inhibition of 
different substances. Human umbilical vein endothelial cells (HUVECs) are widely used 
for this purpose since they are from a human origin and easy to obtain. Here (Figure 13), 
we evaluated the tube network assembly of HUVECs after being cultured during 8 h with 
extractions of the regular media (ERM) from the previous experiments (sections 3.3.2. 
to 3.3.6.). The OM was discarded for this assay due to the significant lower VEGF 
synthesis by the hMSCs (Figure 12B). We used the free available ImageJ plugin 
Angiogenesis Analyzer [15] to evaluate the quality of the produced tube network. 
Selected images of the assay (Figure 13) showed that the HUVECs only produced tubes 
when they were cultured with the ERM, indicating that the release of pro-angiogenic 
factors by the hMSCs was crucial. The absence of tubes when the HUVECs were 
cultured just with regular medium (RM) validates this condition as a negative control 
(NC). 
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Figure 13. Selected images of the HUVECs forming tubes after being 8 h with the 
extracted RM (ERM) form section 3.3.2.. Negative control (NC) consisted of regular 
medium (RM). Quantification of the quality of the tube network using the Angiogenesis 
Analyzer ImageJ plugin [15] A) (n=4). For more information about the analysis please 
refer to Figure 14. Total VEGF B) and L-lactate concentration C) of the different ERM. 
The absence of SEM in B) and C) is due to the media from the different conditions 
were pooled before the assay (see section 3.2.5.4.). Pvalue<0.5 (*), < 0.01 (**), <0.001 
(*), <0.0001 (**). Stars (*) on columns refer to differences with the TCP. 
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Figure 14. Selected image of the HUVECs forming tubs before A) and after B) being 
analyzed with the Angiogenesis Analyzer ImageJ plugin [15]. The different parameters 
measured by the plugin C) (n=4). We used the average of the significant difference 
(Pvalue) with the negative control (NC) of the different parameters, to quantify the quality 
of the tube network in Figure 13A. We considered all the parameters as equal 
important. Pvalue<0.5 (*), < 0.01 (**), <0.001 (*), <0.0001 (**). Stars (*) on columns refer 
to differences with the NC. 
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Analyzing the images with the Angiogenesis Analyzer (Figure 13A), we quantified a 
statistical better tube formation for the ERM from the different scaffolds at day 3 and 13 
than for the ERM from the TCP. This indicates that the contact hMSCs-scaffold induced 
a significant higher angiogenic response. We attributed the lower tube formation for the 
PLA+P30+P55 scaffolds at day 3 to a possible cytotoxic effect of the released MEP 
(Figure 3). The failure in observing cytotoxicity for this scaffold with hMSCs (Figure 9) 
suggests that the HUVECs were much more sensitive to this compound. The lower tube 
formation for the ERM from the scaffolds at day 20 suggests a normalization of the 
angiogenic-promoting effects and a return to a normal state, which we considered 
positive since an excessive blood vessel formation can indicate an abnormal stimulation 
(e.g. tumors) [52]. We could not correlate the tube formation results with an increase in 
the VEGF concentration (Figure 13B). Notice that this time the VEGF was not normalized 
by the total hMSCs DNA since it was considered the total VEGF concentration to have 
an effect in angiogenesis. Although, VEGF is a known angiogenic factor some studies 
have shown it failed to induce in vitro tube formation [48,53,54]. It has been described 
that the VEGF has a role in HUVECs migration, proliferation and tube-maintenance, 
avoiding blood vessel regression rather than stimulating their production [48], and only 
when it was combined with other angiogenic factors such as basic fibroblast growth 
factor (bFGF) or tumor necrosis factor (TNFα) positive results regarding tube formation 
were observed [53]. We could neither correlate the enhancement of tube formation with 
an increase of Ca2+ (Figure 6A) or total L-lactate concentration (Figure 13C), two known 
angiogenic ions [4,5,43,44], which reinforces the hypothesis that other released 
angiogenic factors participated in the tube formation.  
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3.3.8. Formation of initial vasculature in the CAM model 
 
The CAM model is a widely used pre-in vivo test to evaluate the formation of blood 
vessels [16]. It is not subjected to the strict regulations of in vivo experiments due to the 
incapacity of the chick embryo to feel pain during the two first weeks. This facilitates and 
reduces the cost of the experiment, making it available for most research groups. In this 
section, we used the CAM model to evaluate the stimulation of new vasculature by the 
different PLA nanofiber scaffolds (Figure 15). We excluded the PLA+P30 scaffolds due 
to the complexity of the experiment. We used an own developed Image macro to identify 
and quantify the formation of new blood vessels (Figure 16). Analyzing the results (Figure 
15), we observed that the PLA+P30+P55 scaffolds had a similar response than a VEGF-
loaded PLA positive control (PLA+VEGF). On the other hand, the pure PLA nanofibers 
showed a statistical lower amount of blood vessel, validating the PLA+VEGF as a 
positive control and indicating that the particles induced a similar response that such 
angiogenic VEGF doses [55,56]. We did not observe statistical differences between the 
PLA and PLA+P30+P55 scaffolds. However, having the initial hypothesis that the 
particles will increase the formation of blood vessels, the one tailed t-test showed that 
the PLA+P30+P55 scaffolds induced a statistical higher amount [17]. We must also 
consider that the release of L-lactate by the PLA may have smoothen such differences 
due to its angiogenic effect [41–44]. These results indicate that even having similar 
results in the HUVECs tube formation assay (Figure 13A), the scaffolds showed 
differences when implanted in an in vivo-like environment. This supports the statement 
that other factors apart from endothelial cells and the release of angiogenic factors (e.g. 
VEGF) by MSCs were involved in the formation of blood vessels. We also decided to 
implant the scaffolds with hMSCs (Figure 15) since we observed that they released 
significant amounts of VEGF (Figure 12A). Moreover, it has been identified a crosstalk 
between endothelial cells and MSCs in the formation of blood vessels [49,50]. 
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Figure 15. Selected images of the different scaffolds showing the formation of blood 
vessels in the CAM model. Quantification of the small blood vessels within the area of 
the scaffolds using an own developed ImageJ macro A). “+” marked statistical 
differences following a one-tailed t-test. For more information about the macro please 
refer to Figure 16. Pvalue<0.5 (*/+), < 0.01 (**), <0.001 (*), <0.0001 (**). 
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rename("original"); 
run("Split Channels"); 
selectWindow("original (red)"); 
run("Close"); 
selectWindow("original (blue)"); 
run("Close"); 
selectWindow("original (green)"); 
beep(); 
waitForUser("Select your scaffold"); 
run("Cut"); 
newImage("Untitled", "8-bit black", 1360, 1024, 1); 
run("Paste"); 
selectWindow("original (green)"); 
run("Close"); 
run("Set Scale...", "distance=0 known=0 pixel=1 unit=pixel"); 
run("Measure"); 
run("Set Scale...", "distance=0 known=0 p.ixel=1 unit=pixel"); 
selectWindow("Untitled"); 
run("Enhance Contrast...", "saturated=0.3 equalize"); 
run("Invert"); 
run("Subtract Background...", "rolling=50"); 
run("Auto Threshold", "method=IsoData white"); 
run("Duplicate...", " "); 
run("Canvas Size...", "width=1360 height=1024 position=Center zero"); 
run("Gray Morphology", "radius=8 type=circle operator=open"); 
setOption("BlackBackground", false); 
run("Erode"); 
imageCalculator("Subtract create", "Untitled", "Untitled-1"); 
run("Invert"); 
run("Analyze Particles...", "exclude include summarize add"); 
 
 
 
Figure 16. ImageJ macro used to analyze the CAM images in Figure 15. CAM image 
before analysis A). Analyzed images showing all the blood vessels B), the big ones C) 
and the difference D) between B) and C). The macro quantified the pixels from D) and 
from the total area analyzed (selected circle). We normalized D) by the total area 
analyzed. The area occupied by C) was subtracted from the total area analyzed since 
 
 ) B) 
 )  ) 
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the big blood vessels were considered artifacts. Notice that the resolution of the macro 
must be set to the one of the image (here 1360x1024). Parameters like “rolling” and 
“Auto Threshold” can be adjusted to fit better the images. However, all images must be 
treated following the same parameters. Here, we used “rolling=50” and “IsoData white”. 
“Radius=8” extracted the big blood vessels (it can be adjusted). The higher the 
“Radius” the lower the size of the big blood vessels extracted. We used “radius=40” to 
know the pixels occupied by B) and then we calculated the ones from C). The macro 
was mainly developed by Irene Cano Torres, a PhD candidate from the same research 
group. 
 
We implanted the scaffolds after 13 days of culture with the hMSCs because it was then 
when we started to observe significant differences in the VEGF released between both 
scaffolds (Figure 12A). Surprisingly, we observed that even releasing high amounts of 
VEGF, the presence of hMSCs decreased the formation of blood vessels (Figure 15), 
which was unexpected considering the angiogenic stimulation of the PLA+VEGF positive 
control. However, the amount of the VEGF released by the hMSCs in vitro (~5-20 ng/mL, 
Figure 13B) was significantly smaller than the one from the PLA+VEGF condition (200 
ng/30 µL, see section 3.2.6.). We hypothesize that the hMSCs may have died during the 
CAM experiment by an incorrect supply of nutrients, affecting negatively to the formation 
of blood vessels. Another hypothesis is that the formation of extracellular matrix (ECM) 
by hMSCs and the cleaning of the scaffolds during 13 days of culture prior to the CAM 
implantation may have produced a more biocompatible structure that did not need as 
many blood supply, or that the penetration of the blood vessels within this ECM difficulted 
its image analysis. In any case, these results suggest that the incorporation of cells may 
not be a positive choice for the stimulation of initial vasculature and hence a better in 
vivo integration of the scaffolds [57–59]. Despite the lower blood vessel production, we 
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observed again a significant higher amount of blood vessels for the scaffolds containing 
the particles (Figure 15), validating once more their angiogenic potential.  
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3.4. Conclusions 
 
We developed a cost-effective scaffold with angiogenic properties and a promising 
potential in the regeneration/integration of bone and highly vascularized softer tissues. 
The scaffolds released substantial amounts of Ca2+ and PO43- over long periods and 
consisted of electrospun PLA nanofibers with embedded degradable CP nanoparticles 
synthesized by the sol-gel method. We showed a good biocompatibility of the scaffolds 
with hMSCs and a neutral pH under culture condition. Based on the hypothesis that the 
release of Ca2+ would stimulate the formation of blood vessels, we identified that the 
presence of degradable CP nanoparticles enhanced several angiogenic parameters 
such as; the VEGF synthesis by hMSCs, the formation of tubes by HUVECs and the 
production of similar amounts of blood vessels than angiogenic VEGF doses in the CAM 
model. However, we could not correlate such results with increases in the Ca2+ 
concentration. Parallelly, we observed that the presence of the particles increased the 
metabolic activity of hMSCs, resulting in the production of high amounts of L-lactate. The 
high L-lactate concentrations may have had also a role in the observed angiogenic 
stimulation, masking the effects of the Ca2+. The particles also increased the ALP activity 
of hMSCs in an osteogenic medium, suggesting a stronger osteoinductive potential and 
validating their use for bone regenerative applications. However, there was a reduction 
in the VEGF synthesis that suggests a lower blood vessel stimulation in osteogenic-like 
environments. 
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Chapter 4. Evaluating Ca2+ releasing 
proangiogenic sol-gel nanoparticles 
for the healing of chronic skin 
wounds 
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The development of efficient strategies to accelerate the healing of chronic skin wounds 
is still an important challenge. Although several disorders occur in its healing process, 
one of the most significant is an inefficient vascularization (ischemia). Nowadays, the 
use of growth factors (e.g. VEGF) is risky, expensive and difficult to store. Therefore, the 
development of cost-effective and safer strategies is necessary. Our group has 
demonstrated in previous studies that specific Ca2+ concentrations play a role in 
angiogenesis. We observed that the stimulation of extracellular Ca2+-sensing receptors 
(CaSRs) regulates the synthesis of paracrine angiogenic factors. In this chapter, we used 
the P0 particles (here coded as Ca particles) synthesized in Chapter 2 to develop Ca2+ 
releasing platforms in form of dressings for wound healing applications. The presented 
method and product have been protected by means of patent (Ref. N. 
PCT/EP2018/064378). We synthesized the Ca2+ releasing nanoparticles by the sol-gel 
method and tuned their degradability by applying different thermal treatments. We 
combined the nanoparticles with electrospun polylactic acid (PLA) nanofibers to achieve 
easily removal dressings. Particles and scaffolds were characterized by several 
techniques. We demonstrated that the Ca2+ release of the particles could be controlled 
by applying different thermal treatments. The particles treated at 400 ºC (Ca400ºC) did 
not show cytotoxicity when cultured with human dermal fibroblasts (hDFs) and they 
increased the hDFs metabolic activity. We observed a significant improvement in the 
angiogenic response in the ex-ovo chick choriallantoic membrane (CAM) model. Finally, 
we showed that PLA-Ca400ºC electrospun dressings significantly accelerated the 
healing of generated skin pressure ulcers in diabetic and obese mice in comparison to 
conventional Mepilex® dressings, already used in the clinics to treat chronic skin 
wounds. These results highlight Ca2+ releasing dressings as an effective and feasible 
strategy for the treatment of chronic skin wounds. In addition, preliminary in vivo results 
of the dressings in a porcine skin model were very promising.   
 
 
134 
 
4.1. Introduction 
 
The process of skin wound healing can be described as the biological recovery of injured 
“skin”, which comprises the epidermis and dermis [1]. Skin wounds will naturally heal if 
there are not complications such as damage of the deep dermis [2], burns [3], infections 
[4] or alterations of the skin healing mechanisms due to disorders such as diabetes [5] 
or obesity [6]. In such cases, the recovery is much slower and painful, and the wounds 
often become chronic needing constant medical care. To date there are not efficient 
healing treatments for chronic skin wounds [2]. Although the origin of the wound can 
differ (e.g. a deep injure, diabetes, infection, etc.), the difficulty of healing often relies in 
an inefficient vascularization (i.e. ischemic wounds) [1]. Therefore, there is a necessity 
in developing effective treatments to improve the vascularization of ischemic wounds. In 
adults, vascularization occurs through different mechanisms being angiogenesis one of 
the main involved in the regeneration of damaged tissue. Angiogenesis consists on the 
sprouting of microvessels from preexisting capillaries of the surrounding healthy tissue 
[7,8]. The use of growth factors such as the VEGF or certain drugs [9] has demonstrated 
to induce angiogenesis. However, the strict regulations to translate these strategies to 
the clinics due to possible side effects on overdoses, and storage limitations, elevates 
their money-cost and limits their current success [5,7]. Among alternative strategies to 
overcome these drawbacks our group has been focused on the release of certain ions 
(e.g. Ca2+) concentrations to stimulate angiogenesis [10]. It is known that modifications 
in the physiological Ca2+ level play a role in the chemotaxis and proliferation of specific 
cells such as MSCs or EPCs through the stimulation of extracellular Ca2+-sensing 
receptors (CaSRs) [10,11]. What is not as well-understood, is that these CaSRs are also 
involved in the synthesis-regulation of angiogenic factors such as the VEGF [10]. Our 
group has proposed a mechanism which describes it [10], and has showed that Ca2+ 
releasing materials increased the formation of initial vasculature in different animal 
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models [12–14]. In such models, we used degradable calcium phosphate glasses 
synthesized by the sol-gel method to achieve optimal extracellular Ca2+ concentrations. 
However, the simultaneous release of PO43- by these materials can also induce 
mineralization and the stimulation of ectopic bone formation, which would not be ideal 
for the treatment of chronic skin wounds [11,15]. To avoid such responses, we 
prescinded from the use of PO43- and synthesized pure degradable Ca2+ releasing 
nanoparticles. We synthesized the particles by the alkaline precipitation of calcium 2-
methoxyethoxide in an ethanolic medium and we tuned their degradability by applying 
different thermal treatments between 100 and 500 ºC. The presented method and 
product have been protected by means of patent registration under the title 
“CONTROLLABLE ION RELEASE CALCIUM PARTICLES, METHOD FOR 
PRODUCING SAME AND USE THEREOF” (Ref. N. PCT/EP2018/064378). Currently, 
commercial activities are being carried out to out-license the patent to a company 
interested on acquire the related intellectual property (IP) rights. Particle characterization 
includes X-ray diffraction (XRD), infrared spectroscopy (ATR-FTIR), elemental analysis 
(EA), energy dispersive X-ray spectroscopy (EDS), nuclear magnetic resonance (1H 
NMR), scanning electron microscopy (FE-SEM), dynamic light scattering (DLS) and Z-
potential. We evaluated the Ca2+ release of the particles treated at the different 
temperatures in buffered 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
medium (pH 7.4) at 37 ºC. We chose the treated particles at 400 ºC (Ca400ºC) for the 
biological evaluation. Such evaluation included cytotoxicity and viability of the particles 
with human dermal fibroblasts (hDFs) and quantification of the formation of new 
vasculature in the ex-ovo chick choriallantoic membrane (CAM) model. Finally, we 
electrospun such particles in polylactic acid (PLA) nanofibers to produce an easily 
removal dressing. The dressings were characterized by FE-SEM, tensile-strain tests and 
differential scanning calorimetry (DSC). We evaluated the wound healing capacity of the 
dressings by their implantation in generated skin pressure ulcers in diabetic and obese 
male mice and later in a preliminary porcine skin model still under development.      
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4.2. Materials and methods 
 
If not otherwise specified all reagents were purchased from Sigma-Aldrich. 
 
4.2.1. Precursor synthesis  
 
1M calcium 2-methoxyethoxide in 2-methoxyethanol was synthesized as previously 
described [12,13]. Briefly, the right amount of metallic calcium granules PS (98%, 
Panreac) was oxidized in 2-methoxyethanol (99,8%) by refluxing it at the solvent boiling 
point under Ar(g) atmosphere for 24 h. The alkoxide solution was filtered with 0.45 µm 
PTFE hydrophobic Minisart® SRP25 syringe filters (Sartorius AG, Göttingen, Germany) 
and stored under Ar(g) atmosphere at -20 ºC. 
 
4.2.2. Ca2+ releasing nanoparticles synthesis 
 
10 mL of the 1M calcium 2-methoxyethoxide were dissolved in 90 mL of absolute ethanol 
PRS (99,5%, Panreac) at room temperature (RT). Ammonia PA-ACS (30%, Panreac) 
was added dropwise (~30 mL) until a suspension of particles appeared. The suspension 
was left overnight and then we applied two cycles of centrifuged/cleaning at 48384xg for 
20 min with absolute ethanol PRS (99,5%, Panreac) and one last with hexane ACS 
(≥99%). Particles were dried at 70 °C for 2 h and ground in an agate mortar. We coded 
the particles as “Ca” due to their calcium content. The particles were thermal treated at 
100, 200, 300, 400 or 500 °C in a muffle furnace L9/11 (Nabertherm, Lilienthal, Germany) 
for 12 h to study changes in their chemical structure and degradability. Particles were 
weight in a Sartorius CP224S analytical balance (Sartorius AG, Göttingen, Germany) 
before and after thermal treatments to know mass loss. All particles were stored in a 
desiccator under vacuum until characterization analysis. 
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4.2.3. Particle characterization 
 
4.2.3.1. Energy dispersive X-ray spectroscopy (EDS) of the particles at room 
temperature (RT) and 400 °C was performed in a Quanta Q200 scanning electron 
microscopy (SEM) (FEI Company, Hillsboro, OR, USA) coupled with an EDS detector to 
quantify the approximate atomic composition. Measurement parameters include 20 KV 
of emission voltage and 10 mm of working distance. Particles were previously coated 
with a thin carbon layer to improve conductivity.  
 
4.2.3.2. X-ray diffraction (XRD) of the particles at 25, 100, 300 and 500 °C was 
performed in a PANalytical X’Pert PRO MPD Alpha1 Powder diffractometer (PANalytical, 
Almelo, the Netherlands) to determine the crystalline phases. Approximately, 100 mg of 
the particles were pressed in a cylindrical standard sample holder of 16 mm of diameter 
and 2.5 mm of height. Samples were analyzed in a Bragg-Brentano /2  240 mm radius 
geometry. We analyzed the data with the ©PANalytical X’Pert HighScore software 
(PANalytical, Almelo, the Netherlands) and the database PDF2 (2001) from the 
international center of diffraction data (ICDD). 
 
4.2.3.3. Attenuated total reflectance infrared spectroscopy (ATR-FTIR) of the 
particles at 25 and 400 °C was performed in a Spectrum Two FT-IR Spectrometer 
(PerkinElmer, Waltham, MA, USA) and compare with standards of the database ©2005-
2008, Fiveash Data Management, Inc. Approximately 5 mg of the particles were pressed 
in a UATR Diamond/ZnSe accessory (1 reflection). A background without particles was 
performed before each measurement. We used the ©PerkinElmer Spectrum 
(PerkinElmer, Waltham, MA, USA) software to analyze the spectra. 
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4.2.3.4. 1H nuclear magnetic resonance (1H NMR) of the dissolved particles at 25 and 
400 °C in D2O (99.9%) plus 1.5% (v/v) HCl (37%, Panreac) was performed in a Bruker 
400 MHz Avance III spectrometer (Bruker, Billerica, MA, USA) equiped with a Prodigy 
TCl 5 mm cryoprobe to determine the presence of organics. The spectra were registered 
between 16 and -3.8 ppm, applying 3.66 µs, 30° pulse, a delay of 1 s between pulses, 
and an acquisition time of 2.5 s. 32 scans were collected to have a good signal-to-noise 
ratio. Spectra were referenced to the 1H of the deuterium solvent. Data was analyzed 
using the ACD/Spectrus Processor software [16].  
 
4.2.3.5. Elemental analysis (EA) of the particles at the different temperatures was 
performed by combustion in an elemental analyzer EA CE 1108 (Thermo Fischer 
Scientific, Waltham, MA, USA) to determine the C mass percentage. Approximately, 
2000 µg of the particles were weight in a MX5 microbalance (Mettler-Toledo, Greifensee, 
Switzerland). The samples were analyzed by combustion at 1060 ºC using atropine as a 
standard. A mixture of vanadium pentoxide and lead powder was added to facilitate the 
combustion. To determine the organic C content, samples were previously treated with 
6N HCl in Ag capsules to eliminate carbonates. 
 
4.2.3.6. Field emission electron microscopy (FE-SEM) images of the particles at 25 
and 400 °C were performed in a Nova Nano SEM-230 ultra-high resolution field emission 
scanning electron microscopy (FEI Company, Hillsboro, OR, USA). Approximately 1 mg 
of the particles was dispersed in 1 mL of absolute ethanol (99.5%, Panreac) with an 
Ultrasonic Processor UP50H (Hielscher Ultrasonics, Teltow, Germany). 2 µL of the 
dispersion were added on silicon substrates and left to dry at RT. Samples were 
irradiated at 5 KV at a working distance of 5 mm. Particles were coated with a thin carbon 
layer to improve conductivity. 
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4.2.3.7. Dynamic light scattering (DLS) and Z potential of the particles at 400 °C were 
performed in a Zetasizer Nano ZS (Malvern, Worcestershire, UK) to determine particle 
size and surface charge. The particles were dispersed in absolute ethanol (99.5%, 
Panreac), using an Ultrasonic Processor UP50H (Hielscher Ultrasonics, Teltow, 
Germany). Measurements were done in a 10x2 mm precision Quartz Suprasil® cell 
115F-QS (Hellma®Analytics, Müllheim, Germany) or a disposable capillary cell 
(DTS1070) (Malvern Instruments, Worcestershire, UK) for the Z-potential respectively. 
Results were treated with the Zetasizer 7.12 (07/12/2016) (Malvern, Worcestershire, UK) 
software for Windows 7. Size population was expressed in percentage of number of 
particles. 
 
4.2.3.8. Inductively coupled plasma mass spectroscopy (ICP-MS) analysis was 
performed in an Optima 3200 ICP-OES Spectrometer (PerkinElmer, Waltham, MA, USA) 
to determine the Ca2+ release of the particles in aqueous solution. 1 mg of the particles 
at each temperature (25, 100, 200, 300, 400 and 500 °C) was dispersed in 10 mL of 0.05 
M 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) solution at pH 7.4 in 15 
mL centrifuged tubes. Tubes were kept at 37 °C with gentle agitation. After 1, 5, 25, 45, 
69, 94 and 120 h tubes were centrifuged, and 9 mL of the solutions were extracted. The 
tubes were refilled with 9 mL of the HEPES solution and the particles were smoothly 
resuspended using a vortex orbital. Tubes were placed again at 37 °C. 1 mL of each 
extraction was diluted in 9 mL of a 1% (v/v) HNO3 (60%, Panreac) aqueous solution and 
stored at 4 °C for the ICP-MS analysis. The pH of the extractions was measured before 
dilution in a Crison pH-Meter GLP 22+ coupled with a Crison 50 28 pH electrode (Hach 
Company, Loveland, CO, USA).  
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4.2.4. Biological evaluation 
 
Dr. Soledad Perez-Amodio (Senior researcher) and Dr. Claudia Navarro-Requena 
(former PhD candidate) currently working in the same research project, supported me 
with the design and interpretation of the biological evaluation due to their high expertise 
in the biological field. My support in these assays consisted of the supply and 
characterization of the different materials, the support in some of the assays and the 
discussion of the results in this chapter. 
 
4.2.4.1. Human dermal fibroblast (hDFs) viability  
 
We assessed the viability of hDFs with extractions of cell culture media (ECM) in contact 
with the Ca400ºC particles for 24 h. Viability was assessed using alamarBlue TM (Thermo 
Scientific) reagent, following the manufacturer’s instructions. ECM were obtained by 
incubating 3 mg of the Ca400°C particles in 1.5 mL tubes with 1 mL of culture media 
consisting on DMEM no calcium (Gibco) supplemented with 10 % of sterile-filtered fetal 
bovine serum non-USA origin (FBS), 1% of L-glutamine (200 mM, Invitrogen™) and 1% 
of penicillin-streptomycin (104 U/mL, Invitrogen™) at 37 ºC for 1 day.  Tubes were then 
centrifuged and the Ca2+ concentration of the ECM was measured by absorbance 
following a colorimetric method based on the O-Cresolphthalein complexone (Chapter 
2, section 2.2.11.) [17,18]. hDFs from healthy donors (Promocell) at passage 5 were 
seeded on 24-well plates Nunclon™ Delta (ThermoFischer Scientific) at a density of 
15000/well with 380 µL of ECM previously sterilized by filtration. After 1 day of culture 
the ECM was replaced with complete DMEM supplemented with 10% of alamarBlue®. 
The fluorescence intensity of the metabolized alamarBlue® was measured after 3 h at 
560/590 nm in an Infinite M200 Pro Microplate Reader (Tecan Group Ltd., Männedorf, 
Zürich, Switzerland). In addition, we performed a live/dead cell imaging assay to 
qualitatively evaluate cell viability. A live/dead solution was prepared with 4μM of calcein 
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AM (≥96%) and 2μM of ethidium bromide in phosphate buffered saline (Gibco®) solution 
(PBS). Prior to the addition of the live/dead stain, cells were washed with PBS to remove 
any remaining culture media and FBS. Cells were incubated with the live/dead solution 
in dark conditions for 20 minutes prior to imaging. Images were obtained with an Eclipse 
E200 fluorescence microscope (Nikon, Shinagawa, Tokyo, Japan) fitted with a digital 
camera. 
 
4.2.4.2. Ex-ovo choriallantoic membrane (CAM) angiogenic model 
 
We assessed the angiogenic capacity of the Ca400ºC particles using an ex-ovo CAM 
model adapted from [19]. Briefly, fertilized chick eggs (Granja Gibert S.A., Cambrils, 
Spain) were incubated at 37.5 ºC in an SI 24 eggs incubator (Lincu Avitec S.L., Valencia, 
Spain) with air ventilation and a high humid atmosphere. After 3 days the eggs were 
cracked, and the full embryos were placed in Falcon™ standard tissue culture dishes 
100x20 mm (Corning Inc.) surrounded with sterile PBS solution to maintain a high 
moisture level. After 6 more days of incubation, the Ca400ºC particles were dispersed 
using an Ultrasonic Processor UP50H (Hielscher Ultrasonics, Teltow, Germany) in a 2 
mg/mL Opticol™ Rat Type I Collagen (3.8 mg/mL, Cell Guidance Systems) aqueous 
solution at a concentration of 0.5 and 1 % (w/w) of particles respectively. 30 µL of the 
dispersion were added on 6 mm nylon net filters discs (Merck Millipore Ltd.). We also 
included a negative and a positive control of 2mg/mL Opticol™ solution with or without 
200 ng of Recombinant Human VEGF 121 (PeproTech®) respectively. We implanted 32 
replicates per condition in 8 different embryos. The implants were sterilized with UV and 
placed near to the big blood vessels. After 3 days of implantation the embryos were 
sacrificed by decapitation and the discs and the surrounding CAM were fixed with 
Formalin solution neutral buffered (10%). After 25 min, the fixed discs were cut and 
photographed in a MVX10 Macro Zoom Microscope (Olympus Corporation, Tokyo, 
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Japan). The small blood vessels on each scaffold were quantified by using an improved 
version of the ImageJ macro used in Chapter 3, section 3.2.6. (Figure 9). 
 
 
4.2.4.3. In vivo wound healing 
 
We assessed the wound healing capacity of the Ca400ºC particles by incorporating them 
in polylactic acid (PLA) nanofiber dressings and implanting them in generated skin ulcers 
in diabetic and obese mice. 
 
4.2.4.3.1. Pressure ulcer animal model  
 
Eight obese and diabetic mice (8 weeks old) with a db/db mutation in the leptin receptor, 
were ordered from Charles River Laboratories (Wilmington, Massachusetts, USA). Upon 
arrival mice were acclimated in a pathogen-free environment for one week and fed with 
a LabDiet® 5K52 formulation (6% fat) and ad libitum water. Only male mice were used 
to avoid hormonal interference in wound healing due to different animal gender [20–22]. 
Pressure ulcers were performed, as previously reported [23–25], by applying ischemic-
reperfusion cycles using two magnets. Briefly, mice were anesthetized with 5% gas 
isoflurane and maintained slept with a remaining 2% at day 1. The mice backs were 
gently shaved and cleaned with 70% ethanol aqueous solution. The back skin was 
pinched and gently placed between two round ceramic magnets (12x5 mm) for 12 h. 
Mice were monitored until they showed a complete normal awakened state. Six cycles 
of 12 h of magnet-skin-pressure followed by 12 h of rest were performed to generate 
pressure ulcers covered by necrotic tissue. A space of 1 cm of skin exceeded the two 
magnets to obtain two symmetric ulcers per mice separated by healthy tissue. Magnets 
were sterilized with 70% ethanol solution and UV. Mice were not anesthetized for magnet 
replacement and they were treated separately to avoid magnet sticking. During the six 
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magnets-cycles, mice did not show signs of pain. Wounds were treated separately with 
the Ca400°C particles embedded in PLA nanofiber dressings or with conventional 
Mepilex® (Mölnlycke Health Care) already used in the clinics to treat chronic skin 
wounds [26,27], as positive control. During all the experiment we followed the approval 
of the animal care committee of the Catalan government. 
 
4.2.4.3.2. Dressing fabrication 
 
We electrospun the Ca400°C particles with polylactic acid (PLA) nanofibers (PLA-
Ca400ºC) to have a wound dressing that could be easily replaced every day. To do so 
we weighed the right amount of Ca400°C particles to have a mass percentage of 40%. 
The used electrospinning parameters were adapted from previous studies [12,13]. We 
added 15 mL of 2,2,2-trifluoroethanol (TFE) (99,8%, Panreac) and dispersed the 
particles using a Branson Digital Sonifier S-450 (Branson Ultrasonics, Danbury, CT, 
USA). Then we added the right amount of PLA Purasorb PLDL 7038 (Corbion) under 
agitation to have a mass percentage of 4% regarding the TFE solution. Once the PLA 
was dissolved (~4 h) the solution was placed in a 15 mL PP/PE syringe and electrospun 
at ~10 KV and ~12 cm distance tip-to-collector. Fibers were collected on parchment 
paper placed in a grounded cylindrical collector that spun at 120 rpm to homogenize the 
fiber-mat thickness along the rotatory direction while maintaining a random fiber 
distribution. 
 
4.2.4.3.3. Mechanical properties of the dressings  
 
Tensile-strain tests were applied at room temperature using a Zwick-Roell Z0.5TN 
testing machine (Zwick Roell Group, Ulm, Germany) to characterize the mechanical 
properties of the dressings. Four samples per each scaffold were cut into ISO 257-1/2 
standardized test specimens of 50x5 mm, using a stainless-steel punch and a surgical 
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blade. The tensile-strain was calculated on the nominal cross-section area of the 
specimens. We used a caliper and a digital micrometer to measure the exact width and 
thickness of the samples. The average thickness ranged from 50 to 90 µm. The Young’s 
modulus was considered as the slope of the linear region of the tensile-strain curve. The 
ultimate strength was considered as the maximum tensile stress supported by the 
material. The strain to failure was fixed to the previous point before a 40% of loss of the 
tensile strength. The tensile-strain test was monitored at a speed of 10 mm·min-1 using 
a force cell of 10 N. We used the testXpert II testing software (Zwick Roell Group, Ulm, 
Germany) to process the data.  
 
4.2.4.3.4. Differential scanning calorimetry (DSC)  
 
We used a DSC Q20 (TA instruments, New Castle, DE, USA) coupled with a nitrogen 
chiller to determine the thermal properties of the PLA in the scaffolds. Random ~9.4 mg 
pieces of each scaffold were placed in aluminum hermetic pans and were submitted to 
two heating cycles from -90 to 200 ºC at 10 ºC·min-1 with a nitrogen cooling between 
cycles. We determined the crystallization and melting properties of the PLA from the 
curve of the first cycle. From the curve of the second cycle, we assessed the glass 
transition temperature (Tg) applying the inflexion point method. We used the Universal 
Analysis software v4.7A (TA instruments, New Castle, DE, USA) to process de data. 
 
4.2.4.3.5. Dressing implantation  
 
Squares of 1.7x1.7 cm of the PLA-Ca400°C and Mepilex® were used for the 
implantation. Prior to the implantation mice were anesthetized and the necrotic tissue 
from the wounds was mechanically removed using surgical scissors. The 1.7x1.7 cm 
square dressings were sterilized by UV, wet with a 0.9%(w/v) NaCl solution and carefully 
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placed on the wounds. Dressings were covered with adhesive Plaster (Coverplast® 
Latex-free, BSNmedical) and secured with an elastic gauze (Genové Dermatologics). 
Dressings were changed every 24 h placing the animals under anesthesia. After 8 days, 
all mice were sacrificed by cervical dislocation under anesthesia. The wounds were 
excised leaving 2 mm of margin, cut in half and fixed with 10% neutral buffered formalin 
solution for 24 h for histological analysis. 
 
4.2.4.3.6. Wound imaging 
 
At day 0 and before every dressing replacement, wounds were photographed with a 
Mavica FD91 digital camera (Sony, Minato, Tokyo, Japan) and the ORCA-2BT Imaging 
System (Hamamatsu Photonics, Shizuoka, Japan) provided with a C4742-98-LWG-
MOD camera fitted with 512x512-pixel charge-couple device (CCD) cooled at -80 °C. 
The wound area from the images was quantified using the Wasabi image analysis 
software (Hamamatsu Photonics, Shizuoka, Japan) and normalized by the wound area 
at day 0.  
 
4.2.4.3.7. CD31 immunohistochemistry 
 
Histological changes of the fixed wounds at day 8 were evaluated in the full dermis and 
hypodermis. In each sample four regions of interest –ROI- (non-lesioned dermis, 
lesioned dermis, non-lesioned hypodermis, and lesioned hypodermis) were manually 
selected in each tissue section. Formalin-fixed wounded skin tissues were embedded in 
paraffin, cut at 4-5 μm and stained with anti-CD31 antibody (ab28364) or the 
corresponding isotype (ab27478) for the negative control. CD31 antibody was used as a 
marker of endothelial cells to quantify the area of blood vessels. Vessels were defined 
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as CD31 positive labeling. Samples stained with the isotype control tested negative (data 
not shown). Full images of CD31 immunostained sections were acquired by a 
NanoZoomer-2.0 HT C9600 scanner (Hamamatsu Photonics, Hamamatsu, Japan) at 
20X magnification, in which 1 pixel corresponds to 0.46um. QuPAth software [28] was 
used to perform image analysis.  
 
4.2.5. Preliminary porcine model 
 
One female pig (Sus scorfa large white) of 32.4 kg was selected and submitted to one-
week of acclimation period. Preoperatively, the animal was sedated with intramuscularly 
azaperone (4 mg/kg) + ketamine (10 mg/kg) and trachea-intubated. Anesthesia and 
analgesia were induced and maintained with propofol (4 mg/kg), isoflurane (1.5-2%, 
oxygen), and buprenorphine (0.01 mg/kg), respectively. Pre-surgical antibiotic therapy 
was performed with intravenous cephalothin (22 mg/kg). Four skin lesions (2x5 cm2) 
were surgically generated in the dorsal area of the pig. The PLA-Ca400ºC dressings 
were applied in two lesions (treatment) and the other two were left as a control. The 
dressings were replaced at days 4, 8, 12, 18 and 22. The size of the different lesions 
was macroscopically measured by imaging and normalized by the area at day 0. The 
experiment was performed in the Pharmacology, Therapeutics and Toxicology 
department at the Universitat Autonòma de Barcelona (UAB). We obtained the approval 
of the UAB Ethical Committee prior to start the experiment. The animal did not show any 
symptom of disability or morbidity during the experiment. 
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4.2.6. Statistical analysis  
 
Statistical analysis was performed using GraphPad Prism 6 software. We used a two-
tailed t-test to evaluate statistical differences in section 4.2.4.1. The F-test did not show 
statistical differences between variances. We used a one-way ANOVA Tukey’s multiple 
comparison test for section 4.2.4.2. and 4.2.4.3.5., and a two-way ANOVA Tukey’s 
multiple comparison test for section 4.2.4.3.4.. Values in sections 4.2.4.2., 4.2.4.3.4. and 
4.2.4.3.5. passed the D’Agostino-Pearson omnibus normality test, suggesting a 
Gaussian distribution for the values. There were not enough replicates to perform the 
D’Agostino-Pearson omnibus normality test in section 4.2.4.1.. Columns in the graphs 
represent means and error bars show the standard error of the mean (SEM). Statistical 
differences include Pvalue<0.05 (*), <0.01 (**), <0.001 (***) and <0.0001 (****).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
148 
 
4.3. Results and discussion 
 
4.3.1. Particles characterization 
 
As we characterized in Chapter 2, section 2.3.5.1. Ca25ºC particles (labeled as P0-RT 
in Chapter 2) contained the presence of portlandite as a main crystalline phase (Figure 
1A). The X-ray diffraction (XRD) spectrum showed the simultaneous presence of sharp 
and broad diffraction peaks suggesting an anisotropic nanometric crystal size for the 
portlandite [29,30]. Most of these diffraction peaks were highly broad indicating a very 
small nanometric size. However, the sharp peaks referred to bigger diffraction planes 
showing anisotropic crystal dimensions. We attributed the two unidentified XRD peaks 
(marked with a star) to the possible diffraction of some calcium 2-methoxyethoxide 
(CMEO) crystalline planes, although they could also derive from effects on the 
nanometric crystalline size of the portlandite.  
 
 
 
Ca25ºC 
Ca100ºC 
Ca300ºC 
Ca500ºC 
Portlandite 00-004-0733 
Calcite 00-005-0586 
CaO 00-037-1497 
Calcium 2-methoxyethoxide? 
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Figure 1. X-ray diffraction spectra A) and thermogravimetric analysis B) of the particles 
treated at different temperatures. 
 
After the thermal treatment at 100ºC (Ca100ºC), we observed the elimination of such 
peaks, suggesting the degradation of the CMEO. We observed that most of the 
portlandite (Ca(OH)2) was carbonated to calcite (CaCO3) at 300ºC. However, there were 
still traces of portlandite that were not totally carbonated until 500 ºC. We started to 
observe a tiny decarbonation of the calcite to CaO at 500 ºC. The thermogravimetric 
results (Figure 1B) supported this information revealing an increased weight from 250 ºC 
to 400 ºC due to the carbonatation of the Ca(OH)2. Then we observed a significant 
decrease at 600ºC indicating the decarbonation of the CaCO3 to CaO.  
The 1H NMR spectra of the dissolved Ca25ºC particles in acidic D2O (Figure 2A) showed 
the presence of CMEO and EtOH, suggesting that the unidentified peaks form the XRD 
spectra (Figure 1A) could represent some crystalline diffraction planes of the CMEO. We 
observed the elimination of such organics after the thermal treatment at 400ºC (Figure 
2A). The elemental analysis (EA) showed that the total amount of organic carbon (TOC) 
for the Ca25ºC particles was only a ~0.51% of the total weight, indicating a small amount 
B) 
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of CMEO (~1.5%) (Figure 2B). We observed a gradual reduction of the TOC with the 
temperature indicating the decomposition of the CMEO. However, there was a tiny 
amount of TOC (~0.2-0.1 %) from 300ºC to 500ºC, which we attributed to the calcination 
of the CMEO to graphite at such temperatures. This was consistent with the 1H NMR 
results (Figure 2A) that did not show the presence of any organic at 400ºC. In the 
elemental analysis (Figure 2B), we also identified the presence of the carbon form the 
carbonated portlandite (CaCO3) that was included in the total carbon content (TCC). We 
observed an increase of the TCC with the temperature being consistent with an increase 
in carbonatation. Notice that the ~12% of TCC (considering almost no TOC) for the 
Ca500ºC particles means a composition of ~100% of CaCO3. On the other hand, the 
presence of ~3% of TCC and ~0.5% of TOC for the Ca25ºC particles indicates the 
presences of ~20% of CaCO3. We attributed this significant amount of CaCO3 at 25ºC to 
a considerable CO2(g) absorption during particle synthesis or grinding. The absence of 
calcite in the XRD spectrum (Figure 1A) for the Ca25ºC particles indicates an amorphous 
structure for this CaCO3. 
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Figure 2. 1H NMR spectra of the Ca25ºC and Ca400ºC particles dissolved in acidic 
D2O A). Total carbon content (TCC) and total organic carbon (TOC) of the particles 
treated at the different temperatures B). Notice that the identified acetone in A) is 
attributed to impurities in NMR tube cleaning. 
 
 
In fact, the ATR-FTIR spectrum of the Ca25ºC particles (Figure 3A) showed the presence 
of C-O frequency bands, confirming the existence of CaCO3 at 25ºC [31,32]. It also 
revealed Ca-O and O-H bands from the presence of portlandite and some absorbed 
moisture, respectively. We identified an increase in the CaCO3 frequency bands intensity 
at 400ºC indicating a higher amount of CaCO3. The sharper C-O bands at 400 ºC also 
indicate a more well-ordered structure due to crystallization. We did not identify other 
compounds apart from Ca(OH)2 and CaCO3 in the ATR-FTIR spectra, being consistent 
with the EDS analysis of the Ca25ºC and Ca400ºC particles (Figure 3B) that only showed 
the presence of Ca, O and C. Notice that the C detected in the EDS analysis also involves 
the previous graphite coating to improve conductivity (section 4.2.3.1.). 
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Figure 3. ATR-FTIR A) and EDS B) spectra of the Ca25ºC and Ca400ºC particles. 
 
 
 
FE-SEM images showed a particle size slightly >1µm for Ca25ºC and Ca400ºC particles 
(Figure 4). However, the DLS measurements (Figure 5A) of a dispersion of the Ca400ºC 
particles in ethanol showed a smaller size average (324.1±103.9 nm), suggesting an 
aggregation of smaller particles at dried conditions. In fact, we can identify the presence 
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of smaller particles in the aggregates observed in FE-SEM images (Figure 4). The Z-
potential (30.6±10.3 mV) of an ethanolic suspension of the Ca400ºC particles (Figure 
5B) was in the limit range of colloidal stability (~30 mV), suggesting a propensity of the 
particles to form aggregates [33,34] due to the absence of electrostatic repulsion. We 
would like to add that this positive surface charge may enhanced the interaction of the 
particles with aliphatic polyesters with negative Z-potentials such as PLA [35,36], 
resulting in the formation of composites with better wettability and improved mechanical 
resistance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. FE-SEM images of the Ca25ºC and Ca400ºC particles. 
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Figure 5. DLS A) and Z-potential B) measurements of the Ca400ºC particles. The 
different colors refer to three different measurements. 
 
 
Summarizing this particle characterization section, we identified the Ca25ºC particles as 
a mixture of nanocrystalline portlandite with a ~20% of amorphous CaCO3 and a possible 
~1.5% of CMEO. All this calcium phases were carbonated to calcite at 300ºC. However, 
there were still traces of portlandite until 500 ºC. The calcite started to decarbonate to 
CaO between 500 and 600 ºC. The particle size was of several hundreds of nm, however, 
their low positive surface charge (~30 mV) induced the formation of bigger aggregates 
of sizes slightly >1µm. 
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4.3.2. Bioactive degradation of the particles 
 
We measured the Ca2+ release and pH modification of the different thermally treated 
particles, after their immersion in HEPES solution (pH 7.4) at 37 ºC for 5 days (Figure 
6). The particles treated below 300 ºC released high initial Ca2+ amounts due to the 
dissolution of the portlandite. We assigned the sustained slope observed afterwards to 
the more stable amorphous CaCO3, also present in the particles. The decrease in the 
high initial Ca2+ burst between the Ca100ºC and the Ca200ºC particles is related to a 
slightly higher carbonatation at 200 ºC. We attributed the lower Ca2+ burst for the Ca25ºC 
particles to a purity reduction due to the presence of absorbed moisture at 25 ºC, which 
we detected in the ATR-FTIR spectrum (Figure 3A).  
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Figure 6.  Ca2+ release A) and pH modification B) of the particles treated at the 
different temperatures, after their immersion in HEPES media at pH=7.4 and 37 ºC. 
 
 
The Ca2+ release was significantly more sustained from 300 to 500 ºC due to most of the 
portlandite was carbonated to a more stable calcite. We assigned the low initial Ca2+ 
burst of the particles treated at or above 300 ºC to the presence of a small amount of 
portlandite and/or CaO. The slightly decrease in the CaCO3 dissolution slope from 300 
to 500 ºC suggests an increase in calcite crystallinity with the temperature. The pH was 
very basic for the particles treated below 300 ºC due to the dissolution of the portlandite. 
On the other hand, the dissolution of the calcite from the Ca400ºC particles did not modify 
the pH. From these results, we chose a thermal treatment between 300 and 500 ºC to 
achieve particles with controlled sustained degradability able to release angiogenic Ca2+ 
concentrations over time without significant pH modifications. We discarded the particles 
treated below 300 ºC as a biological Ca2+ source due to the high increase in the pH.  
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4.3.3. Human dermal fibroblasts (hDFs) viability  
 
The goal in this Chapter was to improve wound healing through the stimulation of 
vascularization promoted by angiogenic Ca2+ concentrations. Since the Ca400ºC 
particles could maintain significant high Ca2+ concentrations over time without pH 
modifications, we used these particles for the next biological experiments. Human dermal 
fibroblasts (hDFs) are in charge of maintenance and remodeling of the skin and have a 
primordial role in would healing [37]. For this reason, we tested the viability of hDFs with 
extractions of culture media (ECM) in contact with the Ca400ºC particles (Figure 7). The 
live/dead cell assay (Figure 7A) showed a high amount of alive hDFs (green) with a well-
spread morphology after 1 day of culture with the ECM from the Ca400ºC particles. The 
absence of dead cells (red) indicates that the dissolution of the Ca400ºC particles did 
not have any cytotoxic effect on hDFs. The results were similar than a positive control of 
culture media (CM) supplemented with 1 mM of CaCl2, thus validating the 
biocompatibility of the dissolution of the Ca400ºC particles. We did not observe 
significant changes in the color of the Ca400ºC ECM indicating pH neutrality (data not 
shown). We also measured the metabolic activity of the hDFs (Figure 7B). This time, we 
identified a higher metabolic activity for the hDFs cultured with the ECM in comparison 
to the 1 mM CaCl2 culture media. This higher metabolic activity suggests a higher 
number of cells do to a higher cell survival or proliferation promoted by the dissolution of 
the Ca400ºC particles. Surprisingly, we observed that the Ca2+ concentration of the 
Ca400ºC particles in culture media (Figure 7C) was much lower than the one observed 
in HEPES solution (Figure 6B). In fact, it has been reported the insolubility of CaCO3 in 
cell culture conditions [38]. As we stated in Chapter 3, section 3.3.2., we attributed this 
insolubility to the high CO2(g) levels of the incubator and the presence of HCO3- in the 
media. However, we must consider that such CO2(g)/HCO3-(aq) levels may be reduced in 
vivo allowing the dissolution of the particles [39]. Moreover, CaCO3 solubility highly 
increases in slightly acidic environments such as those found in healing wounds [4]. We 
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considered these reasons as a potential likely cause to expect the dissolution of the 
particles in vivo. Therefore, we decided to check their angiogenic and wound healing 
capacities in such conditions (see next sections).  
 
 
 
 
Figure 7. Live/dead staining A) and metabolic activity B) of hDFs cultured for 1 day 
with ECM form the Ca400ºC particles or 1mM CaCl2 CM. Ca2+ concentration of the 
different media C). 
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4.3.4. Formation of blood vessels in the CAM model 
 
We implanted the Ca400ºC particles in the chick choriallantoic membrane (CAM) model 
and we compared the amount of small blood vessels with a negative control (NC) and a 
positive VEGF-loaded angiogenic condition, after 3 days of implantation (Figure 8). The 
ex-ovo CAM model is widely used as a preliminary angiogenic test since the direct 
exposure of blood vessels facilitates their quantification [19]. We evaluated the 
angiogenic properties of the Ca400ºC particles because the success of healing ischemic 
wounds mainly rely on the capacity to restore a proper vascularization [5]. Selected 
images of the different conditions (Figure 8) qualitatively showed a significant higher 
density of small blood vessels for the Ca400ºC particles and the positive VEGF-loaded 
control than for the NC. We quantified the area occupied by the small blood vessels using 
an improved version of the ImageJ macro used in Chapter 3, section 3.3.8. that basically 
simplified the process of image analysis (Figure 9). We also eliminated the nylon net 
artifact pattern (see section 4.2.4.2.) from the images by doing a color deconvolution with 
ImageJ. We found a statistical higher amount of blood vessels due to the presence of 
the Ca400ºC particles (Figure 8B). The absence of statistical differences with the positive 
VEGF-loaded control indicates that the Ca400ºC particles had a similar effect than 
angiogenic VEGF doses. Although the use of angiogenic factors has demonstrated to be 
effective in the formation of blood vessels, it also implies sever risks, storage difficulties 
and a high money-cost [15]. These results highlight that the particles could reduce or 
even substitute the use of angiogenic VEGF doses and avoid these limitations. We did 
not observe statistical differences between the two Ca400ºC particles loads indicating 
the requirement of significant small concentrations (for instance a 0.5% w/w) to reach 
their maximum angiogenic effects.  
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Figure 8. Selected images of the different conditions in the CAM model A). 
Quantification of the small blood vessels/scaffold area using an own developed ImageJ 
macro (Figure 9) B).  
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waitForUser("Select your scaffold"); 
run("Cut"); 
newImage("Untitled", "8-bit black", 2070, 1548, 1); 
run("Paste"); 
run("Set Scale...", "distance=948 known=50 pixel=1 unit=mm"); 
run("Measure"); 
run("Set Scale...", "distance=0 known=0 pixel=1 unit=pixel"); 
selectWindow("Untitled"); 
run("Invert"); 
run("Subtract Background...", "rolling=10"); 
run("Auto Threshold", "method=Moments white"); 
run("Duplicate...", " "); 
run("Canvas Size...", "width=2070 height=1548 position=Center zero"); 
run("Gray Morphology", "radius=6 type=circle operator=open"); 
setOption("BlackBackground", false); 
run("Erode"); 
imageCalculator("Subtract create", "Untitled", "Untitled-1"); 
run("Invert"); 
run("Analyze Particles...", "exclude include summarize add"); 
 
Figure 9. Improved ImageJ macro used to quantify the density of small blood vessels 
in the CAM model (Figure 8). Before running the macro, we applied a color 
deconvolution (Image > Color > Color deconvolution>Vectors > From ROI) with the 
ImageJ software to eliminate the nylon net background (see images form Figure 8A) 
and quantify only the blood vessels. Macro developed by Irene Cano Torres (PhD 
candidate in the same research group) with the help of Dr. Lídia Bardia form the 
Advanced Digital Microscopy department at the Institute for Research in Biomedicine 
(IRB). For more information about the macro parameters please refer to Chapter 3, 
Figure 14. 
 
It is difficult to correlate the observed angiogenic results with a release of Ca2+ since we 
could not measure the Ca2+ concentration in the CAM model. Remember that the 
Ca400ºC particles were practically insoluble under cell culture conditions (section 4.3.3.). 
However, the CAM conditions implied a normal atmospheric CO2(g) level (~0.04 %) much 
lower than the 5% used in the cell incubator. Furthermore, the collagen type I solution 
(section 4.2.4.2.) used to implant the particles did not contain HCO3-. Since we attributed 
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these two parameters to be determinant in the insolubility of the Ca400ºC particles [38], 
we assumed similar Ca2+ release rates than in the HEPES buffered medium (Figure 6A). 
Therefore, we consider the release of significant amounts of Ca2+ by the Ca400ºC 
particles as a potential likely cause of the observed angiogenic improvements.  
 
 
4.3.5. Wound healing capacity in obese and diabetic mice 
 
The absence of cytotoxicity with hDFS (Figure 7) and the angiogenic improvements in 
the CAM model (Figure 8) suggested that the Ca400ºC particles had a promising 
potential to treat ischemic wounds [5]. Therefore, we decided to evaluate their wound 
healing capacities in generated skin pressure ulcers in obese and diabetic mice. The use 
of the right animal models (e.g. diabetic and obese animals) is of paramount important 
since complications arise due to the alteration of the normal skin healing mechanisms in 
comparison to healthy subjects [2]. We generated ischemic pressure ulcers in the mice 
back skin by applying a widely used magnet-reperfusion method (section 4.2.4.3.1.) [23–
25]. In order to have an implantable dressing that could be easily replaced every day, we 
electrospun the Ca400ºC particles in PLA nanofibers. FE-SEM images of the dressings 
(Figure 10) showed random distributed PLA fibers of 2-1 µm of diameter with Ca400ºC 
particles aggregates of ~1 µm embedded inside. The proper packaging of the particles 
inside the fibers suggests a good attractive interaction polymer-particles surface, that we 
attributed to the positive Z-potential of the particles and the negative charge of the PLA 
(Figure 5B) [35,36].  
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Figure 10. FE-SEM images of the PLA nanofiber dressings containing a 40% (w/w) of 
the Ca400ºC particles. We used the same FE-SEM conditions than in section 4.2.3.6.. 
 
For this study, we decided to decrease de load of particles to a 40% in comparison to 
the ≥60% used in Chapter 3 section 3.2.3., and therefore achieve higher mechanical 
properties that withstand better the mechanical stress associated to the mice daily live 
and further porcine model (see section 4.3.6.). The tensile-strain tests (Figure 11A, Table 
1) showed that a 40% of the Ca400ºC particles slightly increased the stiffness (E) of the 
PLA nanofibers, while maintaining a similar ultimate strength (σmax) and a lower but still 
high strain to failure (ɛmax). The improvement in the mechanical properties in comparison 
to the PLA+P30 and PLA+P30+P55 scaffolds in Chapter 3 Figure 5A was attributed to a 
significant reduction (from ≥60% to a 40%) of the load of particles, suggesting a 40% to 
be more suitable to withstand the mechanical stress associated to the implantation 
process. However, the positive Z-potential of the Ca400ºC particles (Figure 5B) may 
have also contributed to maintain the mechanical properties of the PLA nanofibers by 
reinforcing the electrostatic interaction between the polymer (negatively charged) and 
the particles.  
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Figure 11. Tensile-strain tests A) and differential scanning calorimetry (DSC) B) of 
PLA and PLA-Ca400ºC dressings. 
 
Table 1. Young’s modulus (E), ultimate strength (σMax), strain to failure (ɛMax) and PLA 
glass transition temperature (Tg) of PLA and PLA-Ca400ºC dressings. 
  E (Mpa) σMax (Mpa) ɛMax (%) Tg (ºC) 
PLA 93.4±2.46 4.56±0.27 172.4±8.6 57.8 
PLA-Ca400ºC 110.1±6.9 4.19±0.29 94.1±5.7 49.3 
 
 
On the other hand, the DSC results (Figure 11B, Table 1) showed a decrease in the PLA 
glass transition temperature (Tg) due to the presence of the Ca400ºC particles. We 
attributed this decrease to a possible partial degradation, and therefore a shortening of 
the PLA molecular chains, during the electrospinning process. Remember that the 
Ca400ºC particles contained a small proportion of portlandite (Figure 1A), which might 
have increased the pH in the preparation of the PLA solution prior to the electrospinning 
process. The partial shortening of the PLA molecules may have also contributed in the 
observed mechanical changes in Figure 11A. We did not observe any crystallization 
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temperature (Figure 11B), indicating that the PLA in the PLA-Ca400ºC dressings was 
completely amorphous even though the partial shortening of the PLA molecules.  
 
 
 
Figure 12. Selected images of the mice pressure ulcers treated with the Mepilex® and 
PLA-Ca400ºC dressings at different timepoints A). Quantification of the wound area at 
different timepoints B). 
 
We implanted the PLA-Ca400ºC dressings in the generated pressure ulcers and 
quantified the wound area reduction over time. We compared the results with Mepilex® 
positive control dressings already used in the clinics to treat this type of wounds [26,27]. 
Selected images of the wounds (Figure 12A) qualitatively showed a significant smaller 
 
 
            -        
Mepilex® 
PLA-Ca400ºC 
 ) 
B) 
166 
 
 
            -        
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size when treated with the PLA-Ca400ºC dressings than with the Mepilex® at list at day 
7 and 8. We quantified a significant wound reduction (Figure 12B) for the PLACa400ºC 
dressings from day 1 to day 7, while the Mepilex® did not show wound reduction at any 
time point. The differences started to be statistically significant at day 4. These results 
are very promising since we demonstrate that our dressings reduced the wound area to 
almost a 50% in only 7 days, while the commercially available Mepilex® had no 
significant effects in the wound reduction of diabetic and obese mice at such short times. 
Zhang & Xing [26] reported that Mepilex® effectively reduced human diabetic foot ulcers 
at significant longer times (median 49.9 days). Although the skin healing mechanism of 
mice cannot be extrapolated to those from humans, which is expected to be much slower 
[2], our results suggest a quicker recovering using the developed Ca2+ releasing 
dressings.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. CD31 immunochemistry quantification of the mice wounds at day 8. Stars in 
the images point blood vessels. 
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Neovascularization is a key process for the successful healing of wounds. For this 
reason, we analyzed the amount of blood vessels immunolabelled against cluster of 
differentiation (CD31) from histological sections of the wounds at day 8 (Figure 13). 
CD31 also known as platelet endothelial cell adhesion molecule (PECAM-1) is a protein 
found in endothelial intercellular junctions. Since it is present in blood vessels it is very 
useful to evaluate the degree of angiogenesis from tissues [9,12,40]. The results (Figure 
13) showed a higher vascularization in the dermis and hypodermis of the wounds treated 
with the PLA-Ca400ºC dressings than with the Mepilex® control, suggesting that the 
improvements in wound healing were promoted by an increase in vascularization, which 
is consistent with the assumption that the Ca2+ releasing gradients stimulated the 
formation of blood vessels. 
 
 
4.3.6. Preliminary in vivo experiment in a porcine skin model 
 
We would like to add to this chapter a brief paragraph mentioning a preliminary in vivo 
experiment using the PLA-Ca400ºC dressings in generated skin wounds (2x5 cm2) in a 
porcine model. Although we only used one pig with two replicates per condition, we found 
appropriate to add these results due to its relevance. Interestingly, the results showed a 
significant reduction for the wounds treated with the PLA-Ca400ºC dressings regarding 
the absence of dressings (Table 2). The porcine model is very close to the human skin 
healing conditions and hence it is a very confident method to test the wound healing 
capacities of different developed therapies [41,42]. Further experiments in diabetic-
induced pigs are ongoing in order to have better reproducibility and more accurate 
results. 
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Table 2. Wound % reduction of generated skin wounds in a porcine model untreated 
and treated with the PLA-Ca400ºC dressings. Experiment performed by the 
Pharmacology, Therapeutics and Toxicology department at the Universitat Autonòma 
de Barcelona (UAB).  
  4 days 8 days 12 days 18 days 22 days 
No dressing  -13.9  30.6  53.0  75.0  85.0 
No dressing  -8.3  20.6  65.0  78.9  87.2 
PLA-Ca400ºC  -17.2  41.1  74.4  85.6  94.4 
PLA-Ca400ºC  -20.0  36.1  65.0  90.0  95.6 
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4.4. Conclusions 
 
We achieved highly degradable nanoparticles whose Ca2+ release was sustained and 
could be tuned by applying different thermal treatments. Such particles only released 
Ca2+ avoiding a possible mineralization of the wound site induced by the release of other 
ions like PO43-. Particle characterization showed the formation of nanocrystalline 
portlandite and suggested that the control over degradability consisted on the degree of 
conversion of the portlandite to calcite after the different thermal treatments. The 
sustained degradation of the Ca400ºC particles did not show cytotoxicity with hDFs or 
pH modifications, and induced a similar angiogenic response than significant VEGF 
doses in the CAM model. The implantation of PLA electrospun nanofiber dressings 
containing the particles in generated skin pressure ulcers in diabetic and obese mice 
showed a statistical faster wound reduction in comparison to conventional Mepilex®. 
Moreover, CD31 immunochemistry showed a higher vascularization induced by the PLA-
Ca400ºC dressings. A preliminary evaluation (still under development) in a porcine 
model showed also a faster wound reduction for skin wounds treated with the PLA-
Ca400ºC dressings in comparison to their absence. These results are very promising 
and suggest that the production of Ca2+ releasing dressings can be an efficient and cost-
effective strategy to improve the current treatment of chronic skin wounds. 
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General conclusions 
Following the hypothesis that the release of specific Ca2+ concentrations in the body will 
stimulate the formation of blood vessels, we developed a system that modulated the 
bioactive release of Ca2+ for biointegrative purposes. Such system consisted of the sol-
gel synthesis of binary (P2O5:CaO) calcium phosphate glasses (CPg) in the form of 
nanoparticles. We used calcium 2-methoxyethoxide and mono/diethylphosphate as sol-
gel precursors and we controlled the ion release of the particles by modifying their Ca/P 
ratio and applying moderately low thermal treatments. We characterized by NMR 
spectroscopy and other complementary techniques the formation of amorphous calcium 
MEP (CMEP) for the particles before thermal treatment, with the formation of portlandite 
or NH4H2PO4 when there was an excess or the absence of Ca respectively. After thermal 
treatment, the organic CMEP was converted into inorganic ACTMP, ACPP, ACP and 
calcite as the Ca content increase respectively. The solubility of the particles before 
thermal treatment was very high releasing high amounts of Ca2+ and MEP in short 
periods without significant pH modifications. After thermal treatment, the degradability of 
the particles was sustained, releasing for more than two weeks, substantial amounts of 
Ca2+ and Pi without significant pH modifications. To date, there are not studies about 
binary CPg synthesized by the sol-gel method, whose advantages, regarding more 
complex CPg systems (e.g. ternary, quaternary systems), include a straightforward 
synthesis and the absence of extra ions (e.g. SiO44-, Ti4+) with unknown metabolization. 
We used some of the particles to achieve fast or sustained Ca2+ releases in vitro. We 
combined the particles with electrospun polylactic acid (PLA) nanofibers as a platform 
for implantable scaffolds that mimicked the morphology of the natural extracellular 
matrix. The scaffolds induced several angiogenic responses including a higher VEGF 
synthesis by hMSCs and a similar formation of blood vessels in the CAM model than 
angiogenic VEGF doses. The simultaneous release of inorganic phosphate (Pi) by the 
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particles had positive results in the mineralization and osteogenic differentiation of 
hMSCs, suggesting a high potential for bone regenerative applications. Parallelly, we 
used some of the particles to treat chronic skin wounds. Such approach has been 
protected by means of patent (Ref. N. PCT/EP2018/064378). This time, we prescinded 
from the Pi to avoid mineralization in the wound site. We observed that the pure Ca2+ 
releasing nanoparticles combined with PLA nanofiber dressings induced a higher blood 
vessel formation and a significant faster wound reduction in the skin of diabetic and 
obese mice than standard Mepilex® already used in the clinics. These results highlight 
the use Ca2+ releasing dressings as an alternative to the current inefficient chronic skin 
wounds therapies. Concluding, we developed in this thesis an easygoing system that 
induced a proper angiogenic response for tissue regeneration that could minimize the 
use of more sophisticated, expensive and risky strategies like cell therapy or the 
implantation of growth factors.        
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Future work 
A small size and a proper dispersion of the particle filler in a polymer composite is 
essential for a good distribution of properties. The described CPg synthesis method in 
Chapter 2 resulted in the agglomeration of nanoparticles into bigger microaggregates of 
different sizes. A novel sol-gel synthesis method combining an electrospray technique 
has shown to minimize nanoparticle aggregation, resulting in the synthesis of well-
dispersed CPg nanoparticles with a homogeneous size distribution [1]. This method 
consists of electrospraying the sol-gel precursors in a heated silicon bath. The bath high 
temperature (up to 200 ºC) induces the immediate condensation of the precursors into 
solid inorganic nanoparticles. The direct obtention of inorganic nanoparticles minimizes 
aggregation and simplifies the method of synthesis. Moreover, the silicon bath may act 
as a repellent of electrostatic interactions. Modification of parameters like the sol-gel 
precursors concentration suggests a control over the particles size. This method could 
be easily adapted to the CPg formulation presented in this thesis and would simplify the 
obtention of inorganic nanoparticles. However, lower temperature baths should be used 
for the obtention of the organically modified CPg nanoparticles with higher degradability. 
Another parameter affecting in the properties (e.g. mechanical) distribution in a 
composite is the interaction between the filler and the polymer matrix. One of the 
strongest interactions in chemistry is the covalent bonding. Modification of the CPg 
nanoparticle surface with certain molecules can introduce specific functional groups that 
can be used for covalent attachment with biocompatible polymers. For instance, as we 
demonstrated in previous studies [2], the primary amine groups introduced by the 
functionalization of CPg nanoparticles with APTES were linked to the EDC/NHS 
activated carboxylate groups of the PLA. The covalent interaction between polymer and 
filler would improve the mechanical resistance of the developed scaffolds and minimize 
particle detachment after implantation.  
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A different advantage of introducing primary amines in the CPg nanoparticles is their 
functionalization with active molecules like proteins, peptides, polysaccharides, etc. 
Although the use of such molecules can difficult their translation to the market due to 
strict regulations and problems on overdoses, a proper combination of synthetic and 
biological compounds, as well as, a better understanding of their biology is essential for 
the improvement of biomaterials. Biocompatible polymers have served as templates to 
introduce biological molecules, using the reactivity of different functional groups [3]. The 
APTES surface modified CPg nanoparticles will allow their functionalization with active 
molecules [4], translating their use to a wide range of applications such as the delivery 
of growth factors, reduction of inflammatory responses, specific body recognition, DNA 
vectors, etc. On the other hand, doping of the CPg nanoparticles with different ions (e.g. 
Cu2+, Zn2+, Co2+, Ag+) is another alternative to introduce specific bioactivity such as 
antimicrobial properties or a higher angiogenesis. This approach would avoid the strict 
regulations related to biological molecules. However, some of these ions may induce 
cytotoxicity at moderately low doses, as well as, they can reduce the degradability of the 
particles. 
The introduction of the CPg nanoparticles in other scaffolds apart from PLA electrospun 
nanofibers is also another path to explore. It has been demonstrated that the addition of 
CPg nanoparticles increased the survival of embedded hMSCs in a PEG hydrogel [5]. 
The introduction of the developed CPg nanoparticles in cell containing hydrogel like for 
example cross-linked hyaluronic acid could improve cell survival in cartilage regeneration 
applications. 
Regarding Chapter 3, it is evident that the next logical step would be to perform in vivo 
experiments to check the osteogenic capacity of the developed scaffolds. A coherent 
experiment would be their implantation in rat condylar defects, as we did with similar 
scaffolds [6], obtaining positive results. On the other hand, further porcine experiments 
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need to be done with the developed scaffolds in Chapter 4, in other to have a better 
reproducibility in the obtained results and support the developed patent. 
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